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 Carotenoids and vitamin E (α-Tocopherol; αT), the two most plentiful groups of 
lipophilic antioxidants in plants, serve important functions in the human body. The carotenoid 
lutein is prevalent in green leafy vegetables and is one of the most abundant carotenoids in serum 
and tissues. Of particular interest for this thesis, lutein may have critical roles in visual and 
cognitive functions; αT may help maintain neurological health. Since neither component is 
endogenously synthesized by humans, their tissue deposition is solely determined by dietary 
sources. Accumulating evidence have shown that their selective accumulation can suggest their 
functional roles in tissues, especially in the eyes or brain. This dissertation sought to elucidate 
the bioavailability and tissue bioaccumulation of lutein and αT in appropriate animal models.  
 In Chapter 2, we explored the bioaccumulation of lutein in infant rhesus macaques fed 
formulas with high or low levels of carotenoids (lutein, zeaxanthin, β-carotene and lycopene) for 
4 months (n=2/group). All samples were analyzed by HPLC-PDA. This pilot study supports our 
hypothesis that the carotenoid-supplemented infant formula substantially enhanced lutein 
accumulation in various tissues. Since we used only a total of 4 animals and did not have a 
breastfed control group, we performed a larger study in Chapter 3.  
 In Chapter 3, we investigated the bioaccumulation of lutein in infant rhesus macaques 
following breastfeeding or formula feeding. From birth to 6 months, male and female rhesus 
macaques (Macaca mulatta) were either breastfed (n=8), fed a formula supplemented with lutein, 
zeaxanthin, β-carotene and lycopene (n=8), or fed a formula with low levels of these carotenoids 
(n=7). The levels of carotenoids in serum and tissues were analyzed by HPLC-PDA. Breastfed 
infant rhesus macaques demonstrated higher lutein concentrations in serum and brain regions, 
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retina, and other tissues than in formula-fed monkeys, despite similar lutein concentrations in the 
breast milk and carotenoid supplemented formula. Carotenoid supplementation in infant formula 
enhanced lutein deposition in serum and multiple tissues including all examined brain areas, but 
not in the macular retina.  
 In Chapter 4, we asked if the enhanced lutein bioaccumulation in retina (macula and 
periphery) and brain (occipital cortex and cerebellum) of breastfed, compared to formula-fed, 
infant monkeys was associated with higher levels of serum total and HDL cholesterol, 
apolipoproteins, or mRNA/protein expression of carotenoid-related genes (CD36, SCARB1, 
SCARB2, LDLR, STARD3, GSTP1, BCO1, BCO2, or RPE65). Dietary regimen did not impact 
the expression of carotenoid-related genes except for SCARB2. However, carotenoid-related 
genes were differentially expressed across brain and retina regions. Breastfed infants had higher 
serum total and HDL cholesterol, and apolipoproteins than formula-fed infants, suggesting that 
lipoprotein levels might be important for delivering lutein to tissues, especially the macular 
retina, during infancy.  
 In Chapter 5, we demonstrated the distribution of lutein into tissues of an adult rhesus 
macaque after a single oral dose of isotopically-labeled lutein. One 19-year-old female macaque 
was supplemented daily for a year with 1 μmol/kg/day of unlabeled lutein and subsequently 
provided a single oral dose of 1.92 mg of highly enriched 13C-lutein. Plasma, six brain regions, 
retina, and other tissues were collected on the third day post-dose. Lutein accumulation was 
quantified by HPLC-PDA and 13C enrichment was evaluated by LC-Q-TOF-MS. 13C-lutein was 
differentially distributed across various tissues, including multiple brain regions, but was 
undetectable in the retina. We demonstrated that distribution of lutein in the macaque is 
substantially dependent on tissue type.  
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 In Chapter 6, to prepare for a forthcoming pharmacokinetics study with 13C-αT, we 
evaluated the effects of a tocopherol-stripped diet on αT tissue accumulation using wild-type 
(C57BL/6J) mice. Three-week-old weanling mice were fed a tocopherol-stripped diet for either 
one, two, or three weeks during their rapid growth phase (beginning at weaning). At each time 
point, tissue αT concentrations were analyzed by HPLC-PDA. We found that three weeks of 
tocopherol-stripped diet decreased αT concentrations in most tissues, but not in the brain, of 
rapidly growing wild-type mice.  
 In conclusion, we elucidated lutein biodistribution profiles in infant monkeys who were 
breastfed or formula-fed for six months, as well as one possible mechanism to explain the 
differential accumulation of lutein in primate retina and brain. In addition, we determined tissue 
bioaccumulation patterns of a single dose of 13C-lutein using an adult nonhuman primate model. 
Additionally, we verified that a tocopherol-stripped diet for 3 weeks decreases αT levels in 
tissues of growing wild-type mice. Using this model, we will perform an additional study to 
investigate the time-course accumulation of 13C-natural or synthetic αT in various tissues. 
Altogether, this dissertation has contributed novel findings to our understanding of the 
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CHAPTER 1: Literature Review 
 
INTRODUCTION 
 Carotenoids and vitamin E are the two most plentiful groups of lipophilic antioxidants in 
plants and are important components in human diets. Among over 600 carotenoids identified in 
nature, approximately 60 are found in foods (1). However, once ingested, only about 34 
carotenoids are detectable in human serum, and two carotenoids, lutein and zeaxanthin, make up 
~20% of the total carotenoid concentration in serum (2). A few other carotenoids accumulate in 
human tissues, but only lutein, zeaxanthin, and meso-zeaxanthin, concentrate in the macular 
retina, where they have critical functions. Recently, lutein has also been shown to preferentially 
accumulate in human brain regions (3-5), suggesting that it may play a role in brain health. 
Along with lutein, vitamin E has been considered a neuroprotective nutrient, especially during 
development. α-Tocopherol (αT), the most biologically active form of vitamin E, has two forms; 
natural (RRR-) αT derived from plant sources and synthetic (all-racemic) αT, which is comprised 
of equal amounts of 8 stereoisomers. Although αT stereoisomers have equal antioxidant activity 
in vitro, RRR-αT has higher vitamin E activity compared to all-rac αT in vivo. αT has been 
shown to promote brain function and reverses neurological dysfunction caused by vitamin E 
deficiency in animal studies (6, 7). A recent study discovered that RRR-αT is the predominant 
isomer of αT in the human infant brain (8). The preferential deposition of lutein and RRR-αT in 
the brain implies that they may play a role in brain health. Therefore, the bioavailability, 





MOLECULAR STRUCTURES OF LUTEIN AND VITAMIN E  
 Carotenoids are based on a 40-carbon isoprenoid structure with conjugated double bonds 
that give them yellow, orange, or red coloration. Carotenoids are classified as (1) carotenes 
composed of only carbon and hydrogen (e.g. α-carotene, β-carotene, and lycopene) or (2) 
xanthophylls containing at least one oxygen atom (e.g. lutein, zeaxanthin, and β-cryptoxanthin) 
(Figure 1.1A). Carotenoids can also be categorized according to their biological functions, 
including (1) provitamin A carotenoids, which can be metabolized into retinol (e.g. α-carotene, 
β-carotene) or (2) non-provitamin A carotenoids, which do not have vitamin A activity (e.g. 
lycopene, lutein, and zeaxanthin). Each carotenoid has its own distinctive wavelength of 
maximum absorption (λmax) and spectrum shape. When dissolved in ethanol, lutein and 
zeaxanthin absorb maximally at 422, 445, and 474 nm and at 428, 450, and 478 nm, respectively 
(Figure 1.1B). Carotenoids with more conjugated bonds absorb at longer wavelengths. 
 Vitamin E is a family of 8 tocochromanol (tocopherol + tocotrienol) compounds, 4 (α-, β-
, γ-, and δ-) tocopherols and 4 (α-, β-, γ-, and δ-) tocotrienols. All vitamin E forms have a 
hydroxylated chromanol ring and a phytyl side chain. Tocopherols have saturated phytyl side 
chains, while tocotrienols’ phytyl side chains have three double bonds. The extent and location 
of chromanol ring methylation determines the α-, β-, γ-, and δ- designation (Figure 1.1C). αT is 
the most biologically active form of vitamin E in vivo; it will therefore be the focus of this 
literature review. Although αT has 8 possible stereoisomers, only one stereoisomer is found in 
nature (RRR). In contrast, synthetic α-tocopherol, or all-racemic, contains equal amounts of the 8 




Figure 1.1 The structures (A) and absorption spectra (B) of carotenoids, and the structures of 
vitamin E compounds (C). Adapted from Landrum et al. (9). 
 
DIETARY SOURCES OF LUTEIN AND VITAMIN E 
Dietary Sources of Lutein 
 Animals, including humans, cannot synthesize carotenoids de novo. Carotenoid synthesis 
only takes place in plants, algae, bacteria and fungi. Therefore, tissue accumulation of 
carotenoids depends on the diet. Lutein is commonly found in green leafy vegetables, colorful 
fruits, and egg yolks. The richest sources of lutein are dark green leafy vegetables like spinach 
(13.5 mg/100g, cooked) and kale (8.9 mg/100g, cooked), followed by cilantro (7.7 mg/100g), 
parsley (4.3 mg/100g), romaine lettuce (3.8 mg/100g), zucchini (1.4 mg/100g, cooked), and 
broccoli (0.7 mg/100g, cooked) (10). Egg yolk (1.2 mg/100g, cooked) has been reported as a 
highly bioavailable source of lutein (11). Most of the lutein in foods is in the free form (12) 
while supplements often contain esterified lutein due to its heightened stability. Zeaxanthin is 
frequently found in the same foods as lutein, but a typical diet contains more lutein than 
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zeaxanthin. Meso-zeaxanthin has been detected in shrimp shell, fish skin, and turtle fat, but it is 
scarcely found in foods (13).  
 On average, Americans consume < 2 mg/d lutein, with the highest consumption in 71+ 
year-olds (1,008 ± 96 µg lutein/day), based on the 2003-2004 National Health and Nutrition 
Examination Survey (NHANES) (14). Though there is no recommended dietary allowance 
(RDA) for lutein, a daily intake of ~ 6 mg of lutein + zeaxanthin has been associated with a 
decreased risk of age-related macular degeneration (AMD), a leading cause of visual loss in the 
United States (15). Considering this association, Americans’ current lutein intake is well below 
the amount believed to be beneficial for health. Koreans consume on average 2.2 mg of lutein 
and zeaxanthin per day, based on the 2007-2012 Korea National Health and Nutrition 
Examination Survey (KNHANES) (16). Additionally, in recognition of lutein’s importance in 
the diet, Korea’s Ministry of Food and Drug Safety approved a health claim stating that 10-20 
mg/day of lutein may play a role in eye health.   
Bioavailability of Lutein 
 Bioavailability is defined as the fraction of an ingested nutrient that is absorbed and 
available for utilization and/or storage (17). Various factors have an effect on carotenoid 
bioavailability, such as food matrix, processing conditions, the amount/ type of dietary fat, and 
carotenoid interactions (18). Similar to other carotenoids, lutein bioavailability is higher in 
cooked vegetables than raw vegetables (10). The co-presence of dietary fat has been shown to 
increase lutein bioavailability (19). Additionally, lutein from egg yolk results in  a significantly 
higher serum lutein response compared to spinach and lutein supplements, possibly due to its 
lipid matrix, which contains cholesterol, triglycerides, and phospholipids (20). Co-presence of 
other carotenoids in the diet can also affect lutein bioavailability. For example, Micozzi et al. 
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reported that chronic β-carotene supplementation decreased serum lutein concentrations in men 
due to competitive inhibition (21).   
Dietary Sources of Vitamin E 
 The richest dietary sources of vitamin E are edible vegetable oils, with varying vitamin E 
forms and levels. For example, αT is dominant form of tocopherols in wheat germ oil, sunflower 
oil, and safflower oil, whereas γ-tocopherol is rich in corn and soybean oils. Vitamin E is also 
found in processed cereal grains, nuts, fruits, vegetables, poultry, meat, and fish (22). The current 
RDA for adults over 19 years old is 15 mg of αT/day (23). Although dietary sources of vitamin E 
are common, it was reported that most Americans had inadequate dietary intakes of vitamin E; 
specifically, 89% of men and 97% of women over 19 years old and 80% of infants (1-3 years 
old) do not meet the estimated average requirement (EAR) (12 mg and 5 mg of α-tocopherol/day 
respectively) (24). Furthermore, it was reported that vitamin E intake in the majority of 
American children is below the EAR, except for those taking supplements, based on data from 
the 2003-2006 NHANES (25). This may be because the typical US diet includes higher levels of 
γ-tocopherol-rich corn and soybean oils rather than αT-rich oils. Therefore, careful selection of 
dietary sources of vitamin E may be required to meet the current RDA. 
Dietary Sources of Lutein and Vitamin E for Infants: Breastmilk and Infant Formula  
 Breast milk and/or infant formula are the only dietary sources of lutein and vitamin E for 
infants before solid food is introduced. Breast milk provides essential nutrients for growth and 
development as well as bioactive components suited for infant health. Carotenoids (β-carotene, 
lutein, zeaxanthin, lycopene, α-carotene, β-cryptoxanthin) and vitamin E (α-, β-, and γ-
tocopherols) are found in breast milk in concentrations that fluctuate depending on maternal 
dietary patterns, lactation stage, within-feed variation, etc. Maternal dietary patterns greatly 
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affect carotenoid levels in maternal plasma and breast milk (26). Lutein levels in breast milk vary 
between countries, presumably due to differences in carotenoid consumption. A multinational 
study showed that lutein levels in breast milk from Chilean, Chinese, and Japanese women (3.24, 
4.32, 4.38 μg/dL, respectively) are higher than those from US women (1.48 μg/dL) (27). Unlike 
carotenoids, no relationship has been reported between αT levels in maternal plasma and breast 
milk (28, 29). This may be due to a unique mechanism by which vitamin E is transported to the 
mammary glands. Carotenoid and vitamin E levels in breast milk vary depending on the stage of 
lactation; levels are highest in colostrum, and they decline over time, with lowest levels in 
mature milk (30-33). In addition, carotenoid levels in hind milk are higher than in fore or mid 
milk (34).  
 Manufactured infant formulas typically contain only trace amounts of carotenoids, but a 
few infant formulas are now supplemented with carotenoids, including lutein, because of 
carotenoids’ potential health benefits. A randomized double-blind study reported the safety of 
supplementing infant formula with lutein. In that study, infants also showed appropriate growth, 
regardless of whether they consumed lutein-supplemented or unsupplemented infant formula 
(35). Since vitamin E is an essential nutrient, infant formulas routinely include vitamin E. Most 
manufacturers use synthetic αT, but some opt for natural αT. 
Many of the lipophilic nutrients in breast milk are more bioavailable than in infant 
formulas, which may be attributable to the milk fat structure and milk lipases in breast milk (36, 
37). Milk fat globules have a unique structure with a triglyceride core surrounded by milk fat 
globule membrane (MFGM), composed of phospholipids, cholesterol, proteins, and 
glycoproteins. The milk fat globule size distribution varies and can be different depending on 
stage of lactation, nutrition, etc. In contrast, the lipid droplets in infant formula are coated with 
7 
 
casein or whey proteins, which serve as the emulsifiers. These lipid droplets are uniformly sized 
and smaller than milk fat globules. Emulsifier composition and lipid droplet size are known to 
affect lipolysis during absorption. Thus, the noted differences between breast milk and infant 
formula may explain differences in the absorption of lipophilic nutrients. In addition, milk 
lipases in breast milk can aid in the digestion of lipids (38). Although bovine milk-based infant 
formulas also contain milk lipases, their activity is destroyed during pasteurization process.  
ABSORPTION AND METABOLISM OF LUTEIN AND VITAMIN E 
Lutein Uptake, Transport, Retention, and Metabolism  
 Carotenoids are absorbed in a similar way as other lipophilic compounds from the 
gastrointestinal tract. Once carotenoid-containing foods reach the small intestine, carotenoids are 
released from the food matrix by various digestive enzymes and incorporated into lipid droplets. 
The carotenoids are then transferred from the lipid droplets into micelles by the emulsification 
action of bile acids. The micelles are absorbed into the intestinal mucosal cells mainly via 
passive diffusion and partly by facilitated diffusion through receptors such as scavenger receptor 
class B type I (SR-BI) (39). Carotenoids and their metabolites, which are produced through the 
action of the cleavage enzymes β-carotene 15,15′-oxygenase (BCO1) and/or β-carotene 9′,10′ 
oxygenase-2 (BCO2), are packaged into chylomicrons and pass first into lymphatic circulation 
before entering general circulation to be taken up by the liver. Carotenoids can also be taken up 
by peripheral tissues as chylomicrons through the circulation. Intestinal-specific homeobox 
(ISX), a transcription factor, represses the expression of SR-BI and BCO1 to control the β-
carotene absorption and conversion to vitamin A by a negative feedback regulation (40).  
 In the blood, carotenoids are detectable in various types of lipoproteins in varying 
degrees based on their polarity. Non-hydroxylated carotenes like lycopene and β-carotene are 
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transported mainly by low-density lipoprotein (LDL), whereas polar hydroxylated carotenoids 
such as lutein and zeaxanthin are primarily transported by high-density lipoprotein (HDL) and to 
a lesser extent by LDL in the circulation (41, 42). The critical role of HDL in delivering lutein 
was shown in Wisconsin hypoalpha mutant (WHAM) chickens, a HDL-deficient model resulting 
from a mutation of the ATP-binding cassette transporter A1 (ABCA1) transporter gene. WHAM 
chickens fail to accumulate lutein in their retinas even after being fed a high-lutein diet (43).  
 Xanthophylls are highly concentrated in the macular retina because of selective uptake 
and transport, with over 1000-fold higher concentrations in this area than the general circulation. 
To reach the macular retina, lipoprotein-bound xanthophylls must cross the blood-retinal barrier. 
During et al. showed that xanthophylls are selectively taken up by retinal pigment epithelium 
(RPE) cells via a SR-BI-dependent mechanism (44). They also discovered that an HDL-mediated 
SR-BI pathway may be responsible for selective zeaxanthin uptake, while LDL more efficiently 
delivers lutein into the retina—This finding was surprising since, as mentioned, both 
xanthophylls are primarily transported in the circulation via HDL (45). The regulatory 
mechanism of SR-BI in the retina is not yet understood. CD36, a scavenger receptor expressed in 
RPE, may also be involved in xanthophyll uptake into the retina. Genetic variants of CD36 are 
associated with serum lutein levels and macular pigment optical density (MPOD), a noninvasive 
assessment of macular pigment (MP), in AMD patients (46). In addition to SR-BI and CD36, 
SR-BII was shown to be involved in the binding and transport of MP into the retina (47).  
  In the retina, MP is stabilized by binding to selective binding proteins – glutathione S-
transferase P1 (GSTP1) for zeaxanthin (48) and steroidogenic acute regulatory domain protein 3 




Figure 1.2. Absorption, transport, and accumulation of lutein in primate retina. 
αC, alpha-carotene; βC, beta-carotene; BCO1, β-carotene 15,15′-oxygenase; CM, chylomicron; 
LUT, lutein; LRAT, lecithin retinol acyltransferase; RE, retinyl ester; RPE, retinal pigment 
epithelium.  Adapted from Falla et al. (50) and https://i.stack.imgur.com/KBYrq.jpg.  
 
levels of StARD3 in the human brain. This relationship is particularly strong in the pediatric 
brain, but has also been observed in older adults (51). Thus, lutein binding proteins and/or the 
selective transport mechanisms may partially explain the selective accumulation of lutein in the 
brain.   
 There are two identified mammalian carotenoid cleavage enzymes; BCO1 cleaves 
carotenes symmetrically at the 15-15’ carbon-carbon double-bond and BCO2 catalyzes eccentric 
cleavage of carotenes at 9’, 10’ carbon-carbon double-bonds. Work done with purified 
recombinant human BCO1 suggests that BCO1 cannot cleave lutein and zeaxanthin because the 
hydroxylated β-ionone-ring suppresses the activity of this enzyme (52). Interestingly, it was 
reported that MPOD is strongly associated with BCO1 polymorphisms (53), and the role of 
BCO1 in MP deposition is assumed to be indirect. BCO2, unlike BCO1, has a broader substrate 
specificity. BCO2 has been shown to cleave both provitamin A carotenoids and non-provitamin 
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A carotenoids using purified recombinant chicken BCO2 (54). Li et al. recently suggested that 
the unique MP accumulation in the primate retina was related to the inactivity of BCO2 and that 
this was due to loss of an alternate splice site (55). Inactivity of BCO2 was also observed by 
another group, but they suggested that the activity of human BCO2 depends on subcellular 
localization (56, 57). Recently, Shyam et al. revealed a novel function of RPE65 in the retina 
(58). Besides its well-known role as retinol isomerase required for the visual cycle, it has been 
shown that RPE65 can convert lutein to meso-zeaxanthin in vertebrates. This new role of RPE65 
can explain the presence of meso-zeaxanthin in primate retina despite its paucity in the human 
diet.    
 Besides the retina, lutein is deposited in various tissues in unequal amounts, presumably 
due to differential expression of receptors and differences in lipoprotein metabolism among 
tissues. Yonekura et al. showed that lutein and its metabolites differentially accumulated in 
tissues of ICR mice supplemented with lutein esters for 2 weeks (59). Liver had the highest 
lutein/lutein-metabolite concentrations, followed by plasma, adipose tissue, and kidney. Lutein 
bioaccumulation is rarely investigated in humans or non-human primate models, as tissues are 
difficult to obtain. In lieu of other tissues, blood levels of lutein/zeaxanthin and/or MPOD are 
often measured in human subjects. 
α-Tocopherol Uptake, Transport, Retention, and Metabolism  
 Many steps of vitamin E uptake and secretion via chylomicrons in the gastrointestinal 
tract are similar to those of other lipophilic compounds including carotenoids. Vitamin E-
containing chylomicrons from the small intestine are secreted into the lymphatic system and then 
portal blood (Figure 1.3). Chylomicron-bound vitamin E in the circulation can be absorbed into 
peripheral tissues, which may contribute to the accumulation of non-αT forms found in several 
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tissues despite low levels in the plasma (60). Chylomicron remnants are then taken up by the 
liver. In the liver, αT preferentially binds to -tocopherol transfer protein (α-TTP) compared to 
the other vitamin E compounds. Since the non-αT forms are not protected by α-TTP due to lower 
binding affinity (α- > β- > γ- > δ-tocopherol) (61), they are catabolized in liver by cytochrome 
P450 (CYP4F2)-initiated ω-hydroxylation, followed by β-oxidation steps to produce 2’-
carboxyethyl-6-hydroxychroman (CEHC). Subsequently, CEHC is sulphated or glucuronidated 
to be excreted via urine (62). αT is preferentially incorporated into lipoproteins, and this process 
is facilitated by α-TTP and ABCA1. Due to these selective retention mechanisms of αT, > 90% 
of the vitamin E in plasma and tissues is αT, despite the fact that > 70% of the vitamin E in a 
typical US diet is in the form of γ-tocopherol (63). α-TTP is also sensitive to the stereochemistry 
of αT, as it has a 10-fold higher affinity for RRR-αT than the SRR- stereoisomer (61), and thus 





Figure 1.3. Absorption, transport, and metabolism of vitamin E.  
Solid arrows indicate the transport route of vitamin E and dashed arrows indicate catabolism and 
elimination route of vitamin E.  
VE, Vitamin E; CM, Chylomicron; CMr, Chylomicron remnant; 13’-OH, 13’-
hydroxychromanol; 13’-COOH, 13’-carboxychromanol; CEHC, 2’-carboxyethyl-6-
hydroxychroman; αT, alpha-tocopherol; α-TTP, α-tocopherol transfer protein 
 
LUTEIN, α-TOCOPHEROL, AND HEALTH BENEFITS 
Lutein and Eye Health 
 MP, composed of lutein, zeaxanthin, and meso-zeaxanthin, accumulates throughout all 
human ocular tissues except for the vitreous (64). MP is highly concentrated in the center of the 
macula and gives it a yellow color. The concentration of MP decreases with increasing distance 
from the fovea (65). The ratio of lutein and zeaxanthin at a particular retinal location varies 
depending on retinal eccentricity, with zeaxanthin predominating in the foveal center and lutein 
in the periphery (66). The ratio of meso-zeaxanthin to zeaxanthin declines with the increased 
eccentricity to the fovea (67). However, the eyes of developing infants appear to accumulate and 
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metabolize MP differently than mature adult eyes, given the MP bioaccumulation patterns. 
Lutein is the predominant carotenoid in the central retina of infants below age 2 (lutein: 
zeaxanthin ratio = 1.44) in contrast to the eyes of other donors between the ages of 3 and 95 
(lutein:zeaxanthin ratio = 0.77). Notably, the total amount of MP is consistent irrespective of age 
(66). In addition, the ratio of meso-zeaxanthin and zeaxanthin in the whole adult retina is higher 
than that in the infant (0 to 7 month) retina (67). 
 In the macular retina, MP plays a protective role via filtering blue light. Blue light is the 
highest energy form of visible light and possibly induces photo-oxidative damage in the retina. 
Given that the peak absorption of lutein and zeaxanthin (at 445 and 450 nm respectively) 
matches the blue wavelength of light in the visual spectrum (68), MP can reduce the blue light 
intensity. In addition, lutein and zeaxanthin have better blue light filter efficacy compared to 
other carotenoids (lutein > zeaxanthin > β-carotene > lycopene) (69). MP is highly localized in 
the outer and inner plexiform layers (Figure 1.2). This is assumed to be the ideal location for 
protecting the underlying rod and cone photoreceptors from harmful light (70).  
 MP also protects the retina from oxidative damage. The production of reactive oxygen 
species (ROS) is potentially high in the retina, as the rod outer segments are rich in 
polyunsaturated fatty acids that are susceptible to photo-oxidation. Carotenoids including lutein 
and zeaxanthin are considered antioxidants, as they are able to scavenge free radicals and singlet 
oxygen. Therefore, MP’s protective role in the retina may partially explain how lutein and 
zeaxanthin can reduce the risk of AMD. Indeed, epidemiological and large-scale clinical studies 
also suggest that increased intake of lutein and zeaxanthin from dietary sources decreases the risk 
of AMD (71, 72) as well as other ocular diseases, such as cataracts and retinitis pigmentosa (73).  
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 Beyond its role in protecting the eye, MP may also be beneficial for visual performance 
in non-diseased eyes (74, 75) and for early visual development. Deprivation of xanthophylls 
resulted in morphological changes in the foveal RPE of rhesus macaques. This was largely 
reversed by lutein and zeaxanthin supplementation, along with n-3 fatty acids, later in life (76). 
This finding suggests that MP is involved in fovea maturation.  
Lutein and Brain Health 
 Recently, it has been suggested that lutein may have a role in brain health and function, 
since the eye is itself an extension of the neural system. Lutein is the predominant carotenoid in 
the brains of human infants and older adults (3-5). Vishwanathan et al. showed that MP levels 
correlate with lutein concentrations in the brains of primates and humans (5, 77), suggesting that 
MPOD can be used as a surrogate for brain lutein levels. Numerous cross-sectional studies have 
shown that serum lutein and zeaxanthin or MPOD was positively associated with cognitive 
function in adults (Table 1.1). Furthermore, in several randomized, controlled dietary 
intervention studies, lutein supplementation was associated with improved cognitive function in 
adults (Table 1.2). Although the underlying mechanism for lutein’s function in the brain is not 
yet understood, one potential explanation is that lutein can enhance gap junctional 
communication (78). The neuroprotective effects of lutein could also be linked to its antioxidant 
and anti-inflammatory properties.  
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Table 1.1 Cross-sectional studies showing the association of lutein and zeaxanthin with 
cognitive function in adult subjects 
Study Subjects Predictor 
Significant variables 
involved in cognitive function 
p-value 









Global cognition, memory, 
processing speed, attention, 
executive functioning 
p < 0.05 







MPOD3 MMSE4, visual-spatial, 
constructional, and language 
abilities, attention, 







MPOD Visual-spatial and constructional 
abilities  
p < 0.04 
Vishwanathan 






Global cognition, verbal learning and 
fluency, recall, processing 
speed, perceptual speed 
p < 0.05 
Lindbergh et 





Verbal learning and memory p < 0.01 




Plasma LZ Global cognition 











visual memory and performance 
p < 0.01-
0.04 





≥25 kg/m2  
MPOD IQ and fluid intelligence p < 0.01 
Mewborn et 
al., 2018 (85) 
n=51  
(72 ± 2 yrs) 
Serum LZ 
MPOD 
Visual-spatial processing p < 0.01-
0.04 
1LZ, lutein and zeaxanthin; 2MCI, mild cognitive impairment; 3MPOD, macular pigment optical 




Table 1.2 Randomized control trials on the lutein supplementation and cognition in adults 
Study Subjects Intervention 
Significant variables 
related to cognition 
p-value 
Johnson et 






p < 0.03 
Lindbergh et 
al., 2017 (87) 
n=44 
(mean=72yrs) 
L(10mg) + Z2 (2mg)/d,  
12 months 
Learning and recalling 
word pairs 






L (10mg) + Z (2mg)/d,  








al., 2017 (89)  
n=51  
(21±3 yrs) 




complex attention  
p < 0.04-
0.05 





+Z(2mg)/d, 12 months 




1L; lutein, 2Z; zeaxanthin, 3PAL, paired associated learning  
 
 Less is known about lutein’s role in early life. As demonstrated by Vishwanathan et al., 
lutein preferentially accumulated in regions of the infant brain, with highest levels in the auditory 
cortex and the lowest levels in the hippocampus (91). A recent metabolomic study demonstrated 
that lutein concentrations in infant brains were significantly correlated with neurotransmitters 
that are involved in neuronal proliferation and maturation, neurite outgrowth and synapse 
formation (92). Furthermore, an observational study showed that high levels of lutein and 
choline in breast milk were associated with better recognition memory in 5-month old infants 
(93). 
α-Tocopherol and Brain health 
 It is well accepted that vitamin E is critical for the central nervous system (CNS). 
Manifestations of vitamin E deficiency (whether genetic or dietary) include neurological and 
neuromuscular disorders. One notable human disorder called heritable ataxia with vitamin E 
deficiency (AVED) is caused by genetic mutations in α-TTP (94). AVED patients have very low 
plasma levels of αT and progressive ataxia characterized by impaired motor coordination (95). 
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Interestingly, in some vitamin E-deficient patients, high-dose αT supplementation has been able 
to stop the pathologic progression normalize neuromuscular deficits (96). In vitamin E-deficient 
rodents, morphological changes such as axonal swelling, intracellular aggregates of organelles, 
and lipid peroxidation products indicating severe oxidative stress were observed (97, 98). On a 
functional level, vitamin E deficiency manifested as attenuated axonal transport and altered 
mitochondrial respiratory function in rodents (99, 100). In addition, α-TTP knockout (Ttpa–/–) 
mice showed damaged cerebellar Purkinje neurons, the major coordinators of motor output from 
the CNS, and this damage was prevented by vitamin E supplementation. These findings suggest 
that αT is necessary to preserve cerebellar Purkinje cell integrity (7) and more broadly support a 
role for αT in maintaining brain health.  
LUTEIN AND α-TOCOPHEROL IN EARLY LIFE  
Given the above-mentioned roles for lutein in visual and neural development, lutein may be 
of great importance during early life. Lutein administration in the first hours of life increased 
biological antioxidant potential and decreased hydroperoxides compared to untreated human 
newborns who were exposed to oxidative stress (101). Collectively, research findings support the 
hypothesis that dietary lutein has a protective effect for many organs during early life, as lutein 
reaches the infant through multiple means. For example, although not well studied, lutein may be 
transferred from mother to child in utero. MP is detectable in the eyes of prenatal infants 
although the yellow spot is not yet visible (102). Also, lutein is present in cord blood (103), and 
there is a correlation between lutein levels in maternal serum and the levels in the newborn’s 
serum within the first 24-72 hr after delivery (104). The high amounts of lutein found in breast 
milk apparently supports the need for lutein during early life. 
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 αT, especially RRR-αT, may be of importance during early life. During gestation, 
placental transfer of αT is restricted and thus circulating αT levels in newborns are very low 
(105). Interestingly, the placental barrier is able to discriminate between different vitamin E 
forms due to placental α-TTP (105), resulting in higher levels of RRR-αT in human cord blood 
(106). Due to the limited placental transfer of vitamin E, it is critical for infants to consume 
vitamin E from breast milk or infant formula. Furthermore, Kuchan et al. showed that RRR-αT is 
the predominant vitamin E isoform in the human infant brain, despite the fact that infant formula 
is commonly supplemented with all-rac-α-tocopheryl acetate (8). This finding suggests that αT 
stereoisomer profile is important for the infant brain.  
ANIMAL MODELS  
 It is well accepted that the non-human primate model is a favorable choice for 
investigating lutein metabolism and its functional roles in eyes and brain. Only human and non-
human primates have a macular lutea structure with highly concentrated MP. In addition, recent 
studies have shown that lutein is the predominant carotenoid in brain regions of primates (4, 5, 
91). Mice, a commonly-used animal model in carotenoid research, can absorb dietary lutein and 
accumulate small amounts in serum, liver and spleen (107) but they fail to accumulate lutein in 
their retinas and brain. Recently, it was shown that BCO2 knockout mice accumulated 
zeaxanthin in their retinas unlike wildtype mice (55), which supports the notion that lutein 
delivery to mouse retina is inhibited by the oxidative cleavage of lutein by BCO2. Although 
birds have ocular carotenoids like humans, they accumulate esterified forms of carotenoids in 
lipid droplets, which is dissimilar to humans.  
 Rodent models are often used for αT research. In particular, Ttpa–/– mice have been used 
to investigate the role of α-TTP in vitamin E homeostasis. Plasma αT levels in mice are related to 
19 
 
Ttpa genotype (i.e., Ttpa+/+ > Ttpa+/− > Ttpa–/–), thus confirming that α-TTP plays an important 
role in determining plasma levels of the vitamin. Ttpa–/– mice are characterized by vitamin E 
deficiency, oxidative stress, late-onset ataxia, and female infertility, which are similar to AVED 
patients. Wild-type rodents have been also utilized since they maintain the intact vitamin E 
metabolism. Unlike Ttpa–/– mice, it is difficult to deplete vitamin E from tissues of wild-type 
rodents via dietary intervention. Bieri et al. showed vitamin E-deficient diet can gradually 
decrease body αT stores with different rates in various tissues and slower rates in mature rats 
than growing rats (108). Distinctively, the brain is protected against diet-induced vitamin E loss 
compared with other tissues in rats (109).  
AIMS OF DISSERTATION 
 There is a growing interest understanding the bioavailability, bioaccumulation and 
metabolism of lutein or different sources of αT, but much still remains to be clarified. There is a 
need for systematic research utilizing appropriate animal models. Little is known about lutein’s 
biodistribution in early life due to the difficult accessibility of human infant tissues and under-
utilization of non-human primate models. More knowledge in this area will help elucidate lutein 
bioactivity and function. Isotopically labelled tracer methods are an appropriate way to 
determine the bioaccumulation or metabolism of nutrients. However, there is limited research as 
to how lutein or different sources of αT are distributed into the body by utilizing stable isotope 
tracers. Therefore, the aims of this dissertation are to: 
1. Evaluate the impact of differing dietary sources (breast milk vs. infant formula) on lutein 
bioaccumulation in multiple tissues of nonhuman primate infants (Chapter 2 and 3).   
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2. Explore the underlying mechanism resulting in differential lutein accumulation in the 
retina and brain of the infant monkeys via measuring the serum lipids, apolipoproteins, and 
mRNA and/or protein levels of genes related to lutein accumulation (Chapter 4).   
3. Explore the relative uptake and tissue distribution of lutein and two sources of αT by 
utilizing stable isotope tracers in an adult female monkey and young mice, respectively 
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 CHAPTER 2:  
Effect of Carotenoid Supplemented Formula on Carotenoid Bioaccumulation in Tissues of 
Infant Rhesus Macaques: A Pilot Study Focused on Lutein12 
 
ABSTRACT 
 Lutein is the predominant carotenoid in the developing primate brain and retina, and may 
have important functional roles. However, its bioaccumulation pattern during early development 
is not understood. In this pilot study, we investigated whether carotenoid supplementation of 
infant formula enhanced lutein tissue deposition in infant rhesus macaques. Monkeys were 
initially breastfed; from 1 to 3 months of age they were fed either a formula supplemented with 
lutein, zeaxanthin, β-carotene and lycopene, or a control formula with low levels of these 
carotenoids, for 4 months (n = 2/group). All samples were analyzed by high pressure liquid 
chromatography (HPLC). Final serum lutein in the supplemented group was 5 times higher than 
in the unsupplemented group. All brain regions examined showed a selective increase in lutein 
deposition in the supplemented infants. Lutein differentially accumulated across brain regions, 
with highest amounts in occipital cortex in both groups. β-carotene accumulated, but zeaxanthin 
and lycopene were undetectable in any brain region. Supplemented infants had higher lutein 
concentrations in peripheral retina but not in macular retina. Among adipose sites, abdominal 
                                                 
1 This chapter was the result of a collaboration of the following authors: Sookyoung Jeon, 
Martha Neuringer, Emily E. Johnson, Matthew J. Kuchan, Suzette L. Pereira, Elizabeth J. 
Johnson, and John W. Erdman Jr. 
2 Reproduced with permission from Jeon S, Neuringer M, Johnson EE, Kuchan MJ, Pereira SL, 
Johnson EJ, Erdman JW. Effect of Carotenoid Supplemented Formula on Carotenoid 
Bioaccumulation in Tissues of Infant Rhesus Macaques: A Pilot Study Focused on Lutein. 
Nutrients 2017;9(1). Copyright 2017. 
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subcutaneous adipose tissue exhibited the highest lutein level and was 3-fold higher in the 
supplemented infants. The supplemented formula enhanced carotenoid deposition in several 
other tissues. In rhesus infants, increased intake of carotenoids from formula enhanced their 
deposition in serum and numerous tissues and selectively increased lutein in multiple brain 
regions.  
INTRODUCTION 
 Lutein, a yellow xanthophyll pigment, cannot be endogenously synthesized. Therefore, 
humans depend on dietary sources of this carotenoid, especially from green leafy vegetables, like 
kale, spinach, and broccoli (1). Lutein and zeaxanthin are uniquely concentrated in the fovea of 
the primate retina and are known for their beneficial roles in eye health as antioxidants and blue 
light filters (2). Intake of lutein and zeaxanthin from dietary sources is associated with a 
decreased risk of age-related macular degeneration (AMD), a leading cause of irreversible 
blindness in adults (3). In addition to lutein’s impact on eye health, a recent meta-analysis 
reported that higher lutein consumption and higher lutein blood levels were associated with a 
lower risk of coronary heart disease, stroke, and metabolic syndrome (4). Furthermore, lutein is 
increasingly being implicated as having a role in cognitive function (5). Such a role is supported 
by recent studies showing that lutein was selectively deposited in the brains of infant and older 
adults (6,7); that lutein supplementation was associated with improved cognitive function in 
older female subjects (8); and that macular pigment optical density (MPOD) was related to 
cognitive function in older adults (9–11).  
 Emerging evidence suggests that lutein plays important roles in early human 
development. Lutein was the most abundant carotenoid in cord plasma, and its concentration was 
strongly correlated with maternal plasma lutein, suggesting a possible role of lutein in the 
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neonatal period (12). Lutein is the predominant carotenoid in brain in both infants and older 
adults, and its preferential accumulation in the infant brain implies a possible role in central 
nervous system development (5,13). In a metabolomic study, lutein concentrations in infant brain 
were significantly correlated with neurotransmitters that are involved in neuronal proliferation 
and maturation, neurite outgrowth and synapse formation (14). In addition, lutein administration 
in the first hours of life increased biological antioxidant potential and decreased oxidative stress 
(15). Since breast milk or infant formula are the only dietary sources of lutein before solid food 
is introduced (13), it is critical to understand how dietary lutein relates to tissue bioaccumulation 
during early life.  
 Lutein is poorly absorbed and present in negligible levels in the retina and brain of most 
experimental animal models. Amongst non-human animals, only primates selectively accumulate 
lutein and zeaxanthin in their retina/macula and brain (16). Li et al. recently suggested that this 
unique accumulation in primate retina is related to the inactivity of the primary lutein 
mammalian carotenoid cleavage enzyme, β,β-carotene 9′,10′-oxygenase (BCO2) (17) due to loss 
of an alternate splice site. On the other hand, other studies suggested that the activity of human 
BCO2 is conserved and dependent on subcellular localization (18,19). Considering this unique 
metabolism of lutein in primates, the non-human primate is the most relevant animal model for 
investigating lutein’s functional role in the eye and brain. In addition, lutein bioaccumulation 
patterns during the first few months of age are poorly understood, largely because human infant 
tissue samples are not readily available. Since lutein’s unique pattern of accumulation can 
provide clues to its functional role in eyes and brain, we considered it important to describe 
lutein bioaccumulation patterns in developing rhesus macaques. Therefore, we investigated how 
bioaccumulation patterns are influenced by levels of carotenoids in infant formulas. 
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MATERIALS AND METHODS  
Ethics Statement  
 All procedures for this specific study were approved by the Institutional Animal Care and 
Use Committee of Oregon Health and Science University (OHSU IACUC Protocol IS3766) and 
carried out in accordance with the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals.  
Animals and Diets  
 Two male and two female rhesus monkeys (Macaca mulatta) were group-housed with 
their dams from birth until 1–3 months of age; the dams were fed Monkey Diet Jumbo 5037 (Lab 
Diet, St. Louis, MO, USA) supplemented with a variety of fresh fruits and vegetables. The 
infants were then weaned and formula-fed according to detailed protocols for nursery rearing at 
ONPRC. One male and one female, starting at 27 and 86 days old, respectively, were fed a 
formula (Similac® OptiGRO™, Abbott Laboratories, Abbott Park, IL, USA) supplemented with 
lutein, zeaxanthin, β-carotene, and lycopene, and one male and one female, starting at 63 and 26 
days of age, respectively, were fed an unsupplemented formula with low levels of these 
carotenoids. The carotenoid profiles of the two formulas are provided in Table 2.1 and the 
characteristics of the subjects are described in Table 2.2. Upon weaning, infants were hand-fed if 
needed until able to self-feed, with feedings initially four times per day for the younger infants 
and then decreasing to three times per day at 60 days and older. Small amounts of supplemental 
solid foods low in carotenoids were provided daily to older infants. All infants were fed their 
respective formula for a duration of four months. The infants were socialized with infants of 
similar age and housed in cages with age-appropriate blankets, stuffed toys, and other 
enrichment devices. The infants’ health and behavior was monitored daily by primate 
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veterinarians as well as specialists in primate behavior and psychological well-being. The data 
reported here are part of a larger study of the effects of lutein supplementation on retinal and 
brain development. 
Plasma, Serum, and Tissue Collection  
 Fasted 1 mL blood samples were collected in ethylenediaminetetraacetic acid (EDTA) 
and processed to obtain plasma at baseline (before the first formula feeding) and after two and 
four weeks of formula feeding. After four months (133–135 days) of formula feeding, at ages 
162 and 221 days for the supplemented group and 160 and 196 days for the unsupplemented 
group, infant monkeys were humanely euthanized by a veterinary pathologist under deep 
pentobarbital anesthesia, in accord with the recommendations of the Panel on Euthanasia of the 
American Veterinary Medical Association. 
 At the time of death, fasting blood samples were drawn and centrifuged at 800× g for 15 
min to obtain serum. Tissues for carotenoid analysis were collected rapidly, placed in cryotubes 
and frozen in liquid nitrogen. From the brain, samples (approximately 0.5–1 g each) were 
dissected from prefrontal cortex, occipital cortex, superior temporal cortex, striatum, 
hippocampus and cerebellum. From each retina, 4 mm biopsy punches were used to obtain a 
macular sample centered on the fovea and samples of the peripheral retina; the vitreous was 
removed by blotting with filter paper, and the neural retina was gently dissected from the 
underlying retinal pigment epithelium and choroid. 
Carotenoid Analysis  
 All extractions and analyses were performed under yellow light to prevent light-induced 
damage of carotenoids. All extracts were stored under argon at −20 °C for less than 48 h before 
high pressure liquid chromatography (HPLC) analysis.  
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Formula Extraction for Carotenoids 
 To 2 mL of formula was added 10 mL 5% KOH (w/v in methanol) and the mixture was 
vortexed for 15 s. Five mL of tetrahydrofuran (THF) was added and the mixture was vortexed 
for 1 min. Ten mL of extraction solvent (dichloromethane/petroleum ether/hexane, 2:4:4) 
containing 0.005% butylated hydroxytoluene (BHT) was added, vortexed for 1 min, and 
centrifuged at 800× g for 15 min. The upper organic layer was transferred into a test tube. To the 
bottom layer, 10 mL of extraction solvent was added and the extraction process was repeated one 
more time. The extract was pooled and evaporated under nitrogen. To the dried extract were 
added 3 mL deionized water and 3 mL ethanol. This mixture was vortexed for 2 min, sonicated 
for 3 min and centrifuged at 800× g for 5 min at 4 °C. The upper layer was transferred to a 12 × 
75 mm test tube and dried under nitrogen in a water bath (40 °C). The dried extract was 
reconstituted with 50 μL ethanol, vortexed, and sonicated for 30 s. Twenty μL of the 
reconstituted extract was analyzed by HPLC using a semibore C 30 column (20). 
Plasma or Serum Extraction for Carotenoids 
 Plasma or serum carotenoids were extracted as previously described (21). Briefly, about 
250 μL sample was mixed with an equal volume of ethanol containing 0.1% BHT to precipitate 
protein and then vortexed for 30 s. One mL hexane was added, vortexed, and centrifuged at 2400 
rpm at 4 °C (Centrifuge 5417R, Eppendorf, Hamburg, Germany) for 3 min. The upper hexane 
layer was removed. The hexane extraction process was repeated two more times and the extract 
was pooled and evaporated to dryness under argon. 
Brain Extraction for Carotenoids 
 Brain carotenoids were extracted according to the method of Vishwanathan et al. (22). 
Brain samples (0.15 g) were homogenized (Power Gen 500, Fisher-Scientific, Hampton, NH, 
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USA) with 0.3 mL of 0.9% NaCl solution and 0.5 mL ethanol. Echinenone (100 ng) dissolved in 
methanol as an internal standard and 2 mL ethanol were added to the homogenate. The mixture 
was vortexed vigorously for 2 min and the sides of the tube were scraped down. After incubating 
at 70 °C for 2 min, 0.5 mL of freshly-prepared 25% sodium ascorbate and 1 mL of 5% NaOH 
were added. The mixture was saponified in a 60 °C water bath for 20 min. Subsequently, 0.5 mL 
of distilled water was added and the mixture was placed on ice for 5 min. Five mL of hexane was 
added, and the mixture was vortexed for 2 min and centrifuged at 1000× g at 4 °C (Centrifuge 
CR3, Jouan, Winchester, VA, USA) for 10 min. The upper hexane phase was removed and 
reserved. The hexane extraction process was repeated two more times. Hexane was pooled, dried 
using a Speedvac concentrator (model AS160; Savant, Milford, MA, USA), and evaporated to 
dryness under argon. Recovery of the internal standard averaged 80%. 
Retinal Extraction for Carotenoids 
 Retina carotenoids were extracted according to the method of Vishwanathan et al. (22). 
The retinas were weighed and the tissue was ground with 1 mL 0.85% saline by using a glass rod 
on ice. To this, 3 mL chloroform-methanol (2:1, v/v) and 100 ng echinenone (internal standard) 
in ethanol were added. After vortexing for 30 s, the phases were separated by centrifugation at 
800× g at 4 °C (Centrifuge CR3, Jouan) for 15 min. The lower chloroform layer was transferred 
and evaporated to dryness under argon. The extraction was repeated using 3 mL hexane. The 
hexane layer was combined with the first extract and evaporated to dryness under argon. 
Recovery of the internal standard averaged 91%.  
Adipose Tissue Extraction for Carotenoids 
 Carotenoids were extracted from adipose tissues according to the method of Sy et al. 
(23). Briefly, 125 mg of adipose sample was weighed and homogenized (Power Gen 500, Fisher-
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Scientific) with 400 μL Phosphate-buffered saline (PBS). Chloroform (500 μL) and 1 mL 
methanol were added, followed by vortexing for 5 min. After centrifugation at 1200× g at 10 °C 
(Centrifuge CR3, Jouan) for 10 min, the lower phase was collected and evaporated to dryness 
under argon. Ethanol-KOH (1 mL, 5.5%, m/v) and 100 μL of freshly prepared ethanol-pyrogallol 
(1.2%, m/v) were added to the dry residue and vortexed for 1 min. The mixture was incubated at 
37 °C for 90 min for saponification. After incubation, 1 mL distilled water, 100 ng echinenone 
dissolved in ethanol, and 3 mL hexane were added. Carotenoids were extracted by hexanes using 
the above-described steps. Recovery of the internal standard was 100%. 
Extraction of Other Tissues for Carotenoids 
 The extraction method used for other tissues has been previously described (24). Samples 
were manually homogenized with ethanol containing 0.1% BHT, and 1 mL of saturated KOH 
solution was added. After saponification in a 60 °C water bath with intermittent vortexing for 30 
min, 2 mL of deionized water and 6 mL of hexanes were added. Carotenoids were extracted by 
hexanes using the above-described steps.  
HPLC  
 All analyses were carried out on an Alliance HPLC system (e2695 Separation Module) 
equipped with 2998 photodiode array detector (Waters, Milford, MA, USA). Sample extracts 
were reconstituted with 100 μL of ethanol: methyl tert-butyl ether mixture (1:1, v/v) for brain, 
retina, and adipose tissue extracts or 40 μL of mobile phase B for serum and the other tissues. 
The extracts were separated on a reverse-phase C 30 column (4.6 × 150 mm, 3 μm; YMC, 
Wilmington, NC, USA) maintained at 18 °C. A phase gradient method used for carotenoid 
separation was based on the method of Yeum et al. (25). Carotenoids were identified via 
absorption spectra, retention times, and standard comparison and quantified by an external 
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standard curve method or internal standard curve method. Figure 2.1 shows a HPLC 
chromatogram obtained from the serum extract of supplemented formula-fed monkey. 
Statistical Analysis 
 All data were analyzed using SAS software version 9.3 (SAS Institute, Cary, NC, USA). 
Correlations between two variables were determined by Pearson’s correlation coefficient. 
RESULTS 
Formula Carotenoids Profile, Formula Intake, and Body Weight 
 The carotenoid profiles of the two formulas are presented in Table 2.1. The 
supplemented formula contained higher amounts of lutein and β-carotene (15-fold and three-fold, 
respectively), compared to the unsupplemented formula. Lycopene and zeaxanthin were present 
in the supplemented formula but were undetectable in the unsupplemented formula, while α-
carotene and β-cryptoxanthin were not detectable in either formula. Formula consumption ranged 
from 169 to 494 mL/day and increased with age and body weight (Figure 2.2). There were no 
consistent differences in formula intake or body weight between the two formula groups.  
Plasma/Serum Carotenoids 
 Figure 2.3 shows plasma/serum carotenoid concentrations at baseline, and following 2, 
4, and 16 weeks of formula feeding. At baseline, β-cryptoxanthin, α-carotene, β-carotene, 
lycopene, lutein, and zeaxanthin were detected in both groups, and the high baseline values are 
presumably largely due to the highly bioavailable carotenoid supply from breast milk (26). In 
addition, the carotenoid levels at baseline were variable, perhaps due to variable breastmilk 
composition or intake. After 2–16 weeks of formula feeding, levels of all measured carotenoids 
decreased in the unsupplemented formula group. In the supplemented formula group, only serum 
lycopene levels increased at 16 weeks compared to their baseline values, due to the high 
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concentration of lycopene in the supplemented formula. Serum lutein concentrations decreased 
in both groups from baseline to four weeks on formula, but less so in the supplemented group; as 
a result, there was a three-fold difference in serum lutein levels between the two groups at 4 
weeks. By 16 weeks on supplemented formula feeding, serum lutein levels increased slightly 
from levels at four weeks, and were five times higher than in the unsupplemented group. Serum 
zeaxanthin levels dropped until four weeks of formula feeding in both groups; they were 
undetectable in the serum of unsupplemented group by 16 weeks but were maintained in the 
supplemented group from four to 16 weeks. Serum β-carotene levels also were maintained in the 
supplemented group from four to 16 weeks and were two times higher than in the 
unsupplemented group by 16 weeks. Plasma/serum α-carotene and β-cryptoxanthin levels 
gradually decreased in both groups from baseline to 16 weeks since these two carotenoids were 
not present in the formulas. 
Brain Carotenoids  
 Lutein and β-carotene concentrations in the prefrontal cortex, occipital cortex, superior 
temporal cortex, striatum, cerebellum, and hippocampus after 16 weeks on infant formula are 
shown in Figure 2.4. Lutein was differentially distributed across the six brain regions, with the 
highest concentration in the occipital cortex, regardless of the formula type. The supplemented 
formula resulted in a several-fold increase in lutein deposition in all brain regions compared to 
the unsupplemented formula. The lutein concentration in the supplemented group was three-fold 
higher in the occipital cortex and hippocampus (occipital: 64 pmol/g versus 21 pmol/g; 
hippocampus: 30 pmol/g versus 10 pmol/g) and six-fold higher in the striatum (32 pmol/g versus 
5 pmol/g) compared to that of the unsupplemented group. In contrast, in the monkeys fed 
unsupplemented formula, lutein was undetectable in the prefrontal and superior temporal cortices 
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and cerebellum. Small amounts of β-carotene were detected (range: 0–23 pmol/g) across brain 
regions. Neither zeaxanthin nor lycopene were detected in any of the brain samples tested in 
either group. Lutein was the dominant carotenoid in all brain areas regardless of the formula type 
except for the superior temporal cortex, striatum, and cerebellum of the unsupplemented formula 
group in which lutein was undetectable or very low.  
Retinal Carotenoids  
 Lutein and zeaxanthin concentrations in each retinal region are presented in Figure 2.5. 
As expected, lutein and zeaxanthin were present at high levels in the 4 mm diameter macular 
retina, whereas lower levels of lutein were present and no detectable zeaxanthin were present in 
peripheral retina. Mean lutein and zeaxanthin did not differ between formula groups in the 4 mm 
macular retina. However, in the peripheral retina, the mean lutein content was 2.5 times higher in 
supplemented monkeys (196 pmol/g) than in the unsupplemented group (71 pmol/g). β-Carotene, 
lycopene, β-cryptoxanthin, and α-carotene were not detected in any of the retinal regions tested 
in either group. 
 Across all four subjects, serum lutein was strongly correlated with peripheral retina lutein 
(r = 0.98, p = 0.02), but not with 4 mm macular retina lutein (r = −0.09, p = 0.91). 
Adipose Tissue Carotenoids  
 Lutein, β-carotene, and lycopene concentrations in mesenteric (MAT), abdominal 
subcutaneous (ASAT), thigh subcutaneous (TSAT), and axillary brown adipose tissues (BAT) 
are shown in Table 2.3. Among the four different adipose areas, ASAT was the highest in lutein, 
regardless of the formula type. Lutein concentration was increased by supplemented formula in 
all adipose tissues analyzed, with approximately a three-fold increase in the ASAT (112 pmol/g 
versus 43 pmol/g), a two-fold increase in the MAT (39 pmol/g versus 17 pmol/g) and TSAT (88 
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pmol/g versus 39 pmol/g), and a 13-fold increase in BAT (63 pmol/g versus 5 pmol/g). 
Lycopene was not detectable in any adipose samples from the unsupplemented formula group, 
but was the predominant carotenoid in adipose tissues in the supplemented group. There were no 
consistent differences in β-carotene levels in adipose tissues between the groups. 
Carotenoids in Other Tissues 
 Table 2.4 shows the β-carotene, lutein, zeaxanthin, total lycopene, and α-carotene 
concentrations in the liver, spleen, lung, kidney, heart, and quadriceps. Lutein was the 
predominant carotenoid in the liver of both groups. The greatest difference between the formula 
groups was found in the liver, with the supplemented group showing a nine-fold increase 
compared with the unsupplemented group, and higher levels in liver than in any of the other 
organs. Monkeys fed the supplemented formula also had increased lutein concentrations in the 
spleen, lung, kidney, heart, and quadriceps. However, in contrast to the supplemented group, in 
the unsupplemented group the lutein concentration of the liver was similar to that of spleen and 
lung. As in adipose tissues, lycopene was undetectable in the liver, spleen, lung, kidney, heart, 
and quadriceps from the unsupplemented formula group, but present in all cases in the 
supplemented group. β-carotene was present in the liver, spleen, lung, kidney, heart, and 
quadriceps of both formula groups, with somewhat lower levels in the liver, heart and spleen of 
the unsupplemented group. Zeaxanthin and α-carotene were detectable only in the liver of the 
supplemented group, while β-cryptoxanthin was undetectable in all tissue samples. 
DISCUSSION 
 Among dietary carotenoids, lutein is preferentially deposited in the human infant brain 
and retina, a finding that suggests a role in the development of these tissues (13,22). Although 
lutein has been supplemented in some commercial infant formulas, its bioaccumulation pattern is 
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not well understood in early life stages. This pilot study is the first report to describe lutein 
bioaccumulation patterns in nonhuman primate infants fed infant formulas with high or low 
levels of carotenoids.  
 Interest in the potential role of lutein in brain development has been prompted by studies 
showing that this carotenoid is selectively accumulated in the brain of infants, as well as adults 
(6,7). A primary finding of the current study was that four months of feeding a carotenoid 
supplemented formula led to higher concentrations of lutein in all brain regions tested. We also 
determined that lutein accumulated differentially across brain areas. Lutein accumulation was 
highest in the occipital cortex, the primary visual processing area, which is consistent with an 
earlier report on brain carotenoids in xanthophyll-free adult monkeys fed pure lutein (22). In 
contrast, in human tissue, the highest lutein accumulation was found in the cerebellum of 
centenarians (6) and in the auditory cortex of infants (7). This suggests that lutein’s accumulation 
across brain regions might differ between species and/or across the lifespan. While serum levels 
and ratios of carotenoids largely reflected their levels in the two formulas, in the infant brain the 
supplemented formula resulted in a specific and selective increase in lutein, with only small 
amounts of β-carotene and undetectable levels of the other carotenoids despite enhanced intake. 
Notably, we found that lutein was undetectable in prefrontal and superior temporal cortices and 
cerebellum of the unsupplemented formula group. This might suggest differences in the turnover 
rate of lutein across brain regions. Yonekura et al. showed different half-lives of lutein 
metabolites in multiple tissues of male mice as follows: plasma < liver < kidney << adipose 
tissues (27).  
 It is interesting to note that lutein concentration in the lutein-supplemented group was 
increased in the peripheral retina, but not in the 4 mm macular retina. We also observed a 
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correlation between serum lutein and peripheral retina lutein, but not between serum lutein and 
macular retina lutein. One possible explanation is that lutein was preferentially deposited in the 
macular region in the first few weeks of life, prior to the initiation of formula feeding, whereas 
lutein in the peripheral retina continued to increase over the next four months in the 
supplemented group. Johnson et al. previously showed that lutein in both foveal and peripheral 
retina was increased by a high level of lutein supplementation in adult monkeys initially devoid 
of xanthophylls (28). Many human clinical studies show that 2.4–30 mg of daily lutein 
supplementation enhances macular xanthophyll levels, as measured by MPOD, in healthy adults 
and in subjects with retinal diseases (29–33). Johnson et al. also showed that lutein 
supplementation increased MPOD at several eccentricities in older women (34). However, little 
is known about differential lutein deposition in the macular and peripheral retina, particularly in 
early life. These findings might be an important consideration when measuring MPOD in 
children, as several methods for measuring MPOD are based on comparing foveal to more 
peripheral retinal locations with regard to the relative absorption of short wavelength blue light, 
strongly absorbed by lutein and zeaxanthin, to middle wavelength light that is minimally 
absorbed (35).  
 Interestingly, we observed that lycopene, a non-hydroxylated carotene transported mainly 
by low-density lipoprotein (LDL) (36,37), was not found in any brain or retinal region. This lack 
of brain lycopene agrees with findings for the brains of human infants (7), whereas small 
amounts of lycopene (four-fold less than lutein) were found in the brain of centenarians (6). As 
shown in Tables 3 and 4, lycopene is readily taken up in body tissues of infant monkeys. Lutein, 
a polar hydroxylated carotenoid, is primarily transported by high-density lipoprotein (HDL) and 
to a lesser extent by LDL in the circulation (38). In the retina, lutein is taken up via a scavenger 
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receptor class B type I (SR-BI)-dependent mechanism (39), and protected by binding to a 
specific lutein binding protein, steroidogenic acute regulatory domain protein 3 (StARD3) (40). 
Recent findings showed that lutein concentrations are related to levels of this protein in human 
brain (41), and that the relationship is particularly strong in the pediatric brain. Further study is 
required to determine the mechanism underlying preferential uptake of lutein, which may 
involve both HDL transport and StARD3. 
 It is also noteworthy that lutein’s distribution is not homogenous among adipose depots. 
This result parallels a previous study showing site-specific lutein distribution in the subcutaneous 
adipose tissues in healthy human subjects (42). One possible explanation for this regional lutein 
distribution is HDL metabolism. Transport by HDL may enhance lutein uptake into tissues. 
Despres et al. showed in obese patients that more HDL was taken up by subcutaneous adipocytes 
than omental adipocytes (43). This difference may explain the higher lutein accumulation in 
subcutaneous adipose compared to visceral adipose. Furthermore, cholesteryl ester transfer 
protein is known to mediate selective uptake of HDL-cholesteryl ester in human adipocytes, and 
its mRNA expression is up-regulated in subcutaneous fat compared to visceral fat (44,45).  
 Lutein has both antioxidant and anti-inflammatory effects in vitro and in vivo. 
Considering that infants can be at special risk of oxidative stress, lutein’s role as an antioxidant 
may be essential in early life. In an in vitro model of LPS-stimulated macrophages, lutein 
scavenged H2O2 and superoxide anions, decreasing the level of intracellular H2O2 accumulation 
and thereby inhibiting the NF-κB pathway (46). Similarly, lutein treatment reduced the 
expression of inflammatory molecules by suppressing NF-κB activation in three types of cells 
associated with choroidal neovascularization (47). Supplemental lutein prevented 
hypercholesterolemic diet-induced atherosclerosis in guinea pigs by decreasing malondialdehyde 
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and oxidized-LDL (48). In addition, lutein administration in the first hours of life increased 
biological antioxidant potential and decreased hydroperoxides compared to untreated human 
newborns who were exposed to oxidative stress (15). Collectively, these earlier findings support 
the hypothesis that dietary lutein has a protective effect for many organs during early life.  
 In conclusion, in our small pilot study we found that increased early exposure to dietary 
lutein leads to enhancement of lutein tissue deposition. Notably, we found differential deposition 
of lutein in brain and adipose areas. Additional studies will be required to determine if lutein has 
a different half-life across different brain areas and other tissues and, more importantly, if lutein 
has a functional role in development of the brain, retina, and other organ systems.  
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TABLES AND FIGURES 





Lutein 248 16 
Zeaxanthin 23 ND 
β-Carotene 88 32 
Lycopene 362 ND 
β-Cryptoxanthin ND2 ND 
α-Carotene ND ND 
1 Data are expressed in nmol/L; 2 ND, not detected. 
48 
 
Table 2.2 Monkey characteristics. 
Group, Animal ID Gender Age (Days) at Enrollment  
Supplemented formula   
1 Male 27 
2 Female 86 
Unsupplemented formula   
3 Female 26 




Table 2.3 β-carotene, lutein, and total lycopene concentrations in each adipose region. 
Carotenoid Group, Animal ID 
MAT ASAT TSAT BAT 
Mean (Individual Values), pmol/g 
β-carotene 
Supplemented 77 125 56 105 
(1, 2) (49, 105) (91, 159) (68, 45) (107, 102) 
Unsupplemented 82 83 100 59 
(3, 4) (61, 103) (32, 133) (131, 68) (43, 75) 
Lutein 
Supplemented 39 112 88 63 
(1, 2) (25, 53) (71, 154) (69, 107) (78, 47) 
Unsupplemented 17 43 39 5 
(3, 4) (13, 21) (35, 52) (34, 43) (ND, 10) 
Total lycopene 
Supplemented 227 391 350 333 
(1, 2) (162, 291) (280, 502) (220, 481) (295, 371) 
Unsupplemented 
ND1 ND ND ND 
(3, 4) 
MAT: mesenteric adipose tissue; ASAT: abdominal subcutaneous adipose tissue; TSAT: 
thigh subcutaneous adipose tissue; BAT: brown adipose tissue.  
1ND: not detected. 
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Table 2.4 β-carotene, lutein, zeaxanthin, total lycopene, and α-carotene, concentrations in liver, 




Liver Lung Kidney Heart Quadriceps Spleen 
Mean (Individual Values), pmol/g 
β-carotene 
Supplemented 56 134 118 122 116 105 
(1, 2) (51, 61) (125, 142) (121, 115) (124, 120) (117, 115) (86, 125) 
Unsupplemented 29 128 113 57 111 59 
(3, 4) (29, 30) (131, 125) (103, 122) (0, 114) (117, 104) (56, 63) 
Lutein 
Supplemented 505 120 67 60 54 227 
(1, 2) (453, 557) (129, 111) (66, 67) (63, 56) (52, 56) (219, 236) 
Unsupplemented 59 69 35 35 34 67 
(3, 4) (54, 63) (93, 44) (30, 39) (34, 35) (37, 31) (71, 63) 
Zeaxanthin 
Supplemented 34 
ND1 ND ND ND ND 
(1, 2) (33, 35) 
Unsupplemented 
ND ND ND ND ND ND 
(3, 4) 
Total lycopene 
Supplemented 376 209 183 148 150 278 
(1, 2) (253, 500) (174, 243) (167, 198) (134, 161) (105, 194) (139, 418) 
Unsupplemented 




ND ND ND ND ND 
(1, 2) (ND, 35) 
Unsupplemented 34 
ND ND ND ND ND 
(3, 4) (33, 35) 
1 ND: not detected. 
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Figure 2.1 Representative high pressure liquid chromatography (HPLC) separation of 
carotenoids from serum. Peaks: 1, lutein; 2, zeaxanthin; 3, β-cryptoxanthin; 4, α-carotene; 5, β-




Figure 2.2 Body weight (A) of each infant monkey and daily formula intake consumed by infant 
monkeys (B) for 16 weeks. Each symbol represents one animal; solid symbol and solid line 
denote supplemented formula (Sup) while the open symbol and dotted line denote 








Figure 2.3 Plasma or serum total lycopene (A); lutein (B); zeaxanthin (C); β-carotene (D); 
β-cryptoxanthin (E); and α-carotene (F) concentrations of infant monkeys fed either 
supplemented formula (n = 2) or unsupplemented formula (n = 2) for 16 weeks. Each 
symbol represents one animal; solid symbol and solid line denote supplemented formula 
(Sup) while open symbol and dotted line denote unsupplemented formula (Unsup).  
(A) (B) 
  















Figure 2.4 Lutein (A) and β-carotene (B) concentrations in each brain region of infant 
monkeys fed either supplemented formula (n = 2) or unsupplemented formula (n = 2) for 16 
weeks. Each symbol represents individual animal; each column represents mean 
concentration of lutein of two animals. Solid column denotes supplemented formula (Sup) 
while open column denotes unsupplemented formula (Unsup). ND: not detected; PFC: 
prefrontal cortex; OC: occipital cortex; STC: superior temporal cortex; ST: striatum; CB: 







Figure 2.5 Lutein (A) and zeaxanthin (B) concentrations in each retina region of infant 
monkeys fed either supplemented formula (n = 2) or unsupplemented formula (n = 2) for 16 
weeks. Each symbol represents individual animal; each column represents mean 
concentration of lutein of two animals. Solid column denotes supplemented formula (Sup) 
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CHAPTER 3:  
Lutein is Differentially Deposited across Brain Regions Following Formula or Breast 
Feeding of Infant Rhesus Macaques12 
 
ABSTRACT 
 Lutein, a yellow xanthophyll, selectively accumulates in primate retina and brain. Lutein 
may have a critical role in neural and retinal development, but few studies have investigated the 
impact of dietary source on its bioaccumulation in infants. We explored the bioaccumulation of 
lutein in infant rhesus macaques following breastfeeding or formula-feeding. From birth to 6 
months, male and female rhesus macaques (Macaca mulatta) were either breastfed (BF) (n=8), 
fed a formula supplemented with lutein, zeaxanthin, β-carotene and lycopene (237, 19.0, 74.2, 
and 338 nmol/kg, supplemented formula-fed; SF) (n=8), or fed a formula with low levels of 
these carotenoids (38.6, 2.3, 21.5, and 0 nmol/kg, unsupplemented formula-fed; UF) (n=7). The 
levels of carotenoids in serum and tissues were analyzed by HPLC. At 6 months, the BF group 
exhibited significantly higher lutein concentrations in serum, all brain regions, macular and 
peripheral retina, adipose tissue, liver and other tissues compared to both formula-fed groups (P 
< 0.001). Lutein concentrations were higher in the SF group than the UF group in serum and all 
tissues, with the exception of macular retina. Lutein was differentially distributed across brain 
                                                 
1This chapter was the result of a collaboration of the following authors: Sookyoung Jeon, 
Katherine M. Ranard, Martha Neuringer, Emily E. Johnson, Lauren Renner, Matthew J. Kuchan, 
Suzette L. Pereira, Elizabeth J. Johnson, and John W. Erdman, Jr. 
2Reproduced with permission from Jeon S, Ranard KM, Neuringer M, Johnson EE, Renner L, 
Kuchan MJ, et al. Lutein Is Differentially Deposited across Brain Regions following Formula or 
Breast Feeding of Infant Rhesus Macaques. J Nutr 2018;148:31-9. Copyright 2018. 
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areas, with highest concentrations in the occipital cortex, regardless of the diet. Zeaxanthin was 
present in all brain regions but only in the BF infants; it was present in both retinal regions in all 
groups but was significantly enhanced in BF infants compared to either formula group (P < 
0.001).  β-carotene accumulated across brain regions in all groups, but was not detected in retina. 
While lycopene was found in many tissues of the SF group, it was not detected in brain or retina. 
Although carotenoid supplementation of infant formula significantly increased serum and tissue 
lutein concentrations compared to unsupplemented formula, concentrations were still well below 
those in BF infants. Regardless of diet, occipital cortex showed selectively higher lutein 
deposition than other brain regions, suggesting the lutein’s role in visual processing in early life.  
INTRODUCTION 
 Breast milk provides essential nutrients for growth and development, as well as other 
bioactive components that promote infant health. The composition of breast milk serves as a 
template for infant formula, but its nutrient profile is difficult to duplicate (1). Carotenoids 
including lutein, zeaxanthin, canthaxanthin, β-cryptoxanthin, α-carotene, β-carotene, and 
lycopene are detected in breast milk in concentrations that vary with maternal diet as well as the 
stage of lactation (2-7). Among the carotenoids in breast milk, lutein has gained particular 
interest in recent years because of its potential role in visual and neural development (8). 
 Because humans cannot endogenously synthesize lutein, a yellow xanthophyll, it must be 
obtained from dietary sources such as dark green leafy vegetables, colorful fruits, and eggs (9). 
Lutein and its isomer zeaxanthin, known as macular pigments, selectively accumulate in the 
fovea of the primate retina, where they may provide protection from harmful short-wavelength 
blue light and act as antioxidants and/or anti-inflammatory agents (10). Epidemiological and 
large-scale clinical studies have shown that increased intake of lutein and zeaxanthin is 
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associated with decreased risk of age-related macular degeneration, a leading cause of 
irreversible visual loss in older adults (11, 12). Studies of lutein and zeaxanthin supplementation 
have shown positive effects on visual performance in healthy subjects and those with age-related 
macular degeneration (13-15).  
 Recent evidence suggests that, compared to other carotenoids, lutein preferentially 
accumulates in brains of human infants and older adults (16-18). Considering that the retina is an 
extension of the central nervous system, the presence of neural lutein implies a role in brain 
function. In intervention studies, lutein intake was associated with improved cognitive function 
in healthy adult subjects (19, 20). Recently, studies using functional magnetic resonance imaging 
or event-related potentials revealed that macular pigment optical density (MPOD) and serum 
xanthophyll levels were associated with enhanced neural efficiency in older adults and children 
(21, 22). Less is known about lutein’s role in infancy. A recent metabolomic study demonstrated 
that lutein concentrations in infant brains were significantly correlated with amino acid 
neurotransmitters (23). Furthermore, higher levels of lutein and choline in breast milk were 
associated with better recognition memory in 5-month-old infants (24). 
 Macaque monkeys are an appropriate animal model for investigating the potential benefits 
of lutein in humans because, unlike rodents, they accumulate xanthophylls in the retina and brain 
(25). Considering the possible roles of lutein in the developing eye and brain, and its potential 
life-long impact, achieving optimal lutein status in early life may be important for adult retina 
and brain health. Breast milk or infant formula are the sole sources of nutrition for infants before 
solid food is introduced. Therefore, more information is needed on the effects of dietary 
carotenoids from breast milk or infant formula on tissue lutein accumulation during early life.  
 To date, lutein bioaccumulation in response to diets during infancy has been poorly 
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understood. Serum lutein and β-carotene concentrations, but not other carotenoids, were reported 
in infants fed breast milk or infant formulas with different amounts of lutein (26). In our previous 
study, we reported that carotenoid-supplemented infant formula increased lutein deposition in 
multiple tissues including brain and retina of young infant rhesus macaques fed for 4 months 
(27). In the current study, a breastfed reference group was compared with infant formula-fed 
groups after six-months of feeding. The objective of this study was to compare how carotenoid 
bioaccumulation patterns in infant nonhuman primates were influenced by breast milk, an infant 
formula with low carotenoid levels, or a similar formula supplemented with lutein, zeaxanthin, β-
carotene and lycopene.  
MATERIALS AND METHODS  
Animals and Diets  
 All live animal aspects of the study were conducted at the Oregon National Primate 
Research Center (ONPRC) at Oregon Health and Science University (OHSU). All procedures 
were approved by the Institutional Animal Care and Use Committee of OHSU and carried out in 
accordance with the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals. Newborn rhesus macaques (Macaca mulatta, all of the Indian-origin subspecies) were 
obtained from the ONPRC breeding colony and allocated on the day after birth into three groups: 
breast milk (BF, n=8), carotenoid-supplemented formula (SF, n=8) (Simlac Advance with 
OptiGRO), or an unsupplemented formula (UF, n=7) manufactured using the Similac Advance 
base formulation including DHA. The supplemented formula contained, by analysis, 22.1 
μmol/kg of RRR-α-tocopherol and the unsupplemented formula contained 36.6 μmol/kg of all-
rac-α-tocopherol. Randomization among the groups was stratified by gender and by birth weight 
below or above the median (400-485 versus 486-550 g for females and 420-506 versus 507-610 
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g for males). The characteristics of the infant monkeys are described in Table 3.1.  Ready-to-
feed formulas were manufactured and labelled with a numerical code by Abbott Nutrition 
(Columbus, Ohio). Investigators and all staff working with the infants were masked to the 
identity of the two formulas until sample analysis was complete.  
 BF infant monkeys were housed with their dams from birth; the dams were fed Monkey 
Diet Jumbo 5037 (Lab Diet, St. Louis, MO, USA) supplemented with a variety of fresh fruits and 
vegetables. Formula-fed infants were nursery-reared from one day after birth according to 
established protocols at ONPRC. They were housed in incubators for 2-4 weeks and gradually 
weaned to cage-housing with another age-matched member of the same diet group and provided 
with blankets, stuffed toys and a variety of enrichment devices.  Infants were initially hand-fed 
until able to self-feed from a bottle-feeder by 3-10 days of age; feedings were provided every 2-4 
hours around the clock until approximately day 10 and then 3-4 times per day. Volume of intake 
was recorded at each feeding daily from day 1 through 12-13 weeks of age and then for 5 
consecutive days every 4 weeks until 24 weeks. Color-coded sterilized bottles were filled with 
age-appropriate volumes of formula once per day, refrigerated until needed, and then warmed in 
a water bath; any formula not consumed within four hours was removed and discarded. All infant 
monkeys were fed their designated diet for 6 months (25 weeks). The health and food intake of 
all animals was continuously monitored by veterinary staff.  
Serum/Plasma, Tissue, and Breast Milk Collection  
Fasting 1 mL blood samples from study animals were collected in EDTA and processed 
for plasma at baseline (1 day after birth) and after 4, 8, 12, 16 and 24 weeks of breast milk or 
formula feeding. Breast milk samples were collected by manual expression under ketamine 
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sedation (5-10 mg/kg IM).  Samples were collected directly into cryotubes, frozen on dry ice, 
and stored at -80° C until analysis. 
 After 6 months of breastfeeding or formula feeding, infant monkeys were humanely 
euthanized by a veterinary pathologist under deep pentobarbital anesthesia, according to the 
recommendations of the Panel on Euthanasia of the American Veterinary Medical Association. 
 At the time of death, fasting blood samples were drawn and centrifuged at 800× g for 15 
min to obtain serum. Tissues for carotenoid analysis were collected rapidly, placed in cryotubes, 
frozen in liquid nitrogen, and then stored at -80° C until analysis. From the brain, samples 
(approximately 0.5-1 g each) were dissected from dorsolateral prefrontal cortex, occipital cortex, 
superior temporal cortex, striatum, cerebellum, motor cortex, isolated frontal gray matter, frontal 
white matter, and hippocampus.  From each retina, 4 mm diameter biopsy punches were used to 
obtain a macular sample centered on the fovea and samples of the peripheral retina; the vitreous 
was removed by blotting with filter paper, and the neural retina was gently dissected from the 
underlying retinal pigment epithelium and choroid.  Samples were collected from other tissues 
including adipose tissue, liver, quadriceps, kidney, heart, lungs, spleen, and ovaries or testes.  
Samples of adipose tissue were collected from 4 sites: abdominal subcutaneous (ASAT), 
mesenteric (MAT), thigh subcutaneous (TSAT), and axillary brown adipose tissues (BAT). 
Carotenoid Analysis  
 All extractions and analyses were performed under yellow light to minimize light-
induced damage of carotenoids. Carotenoids were extracted from serum/plasma and multiple 




 For breast milk and formula analysis, 10 mL of 5% KOH in methanol was added to 2 mL 
of breast milk or formula and vortexed. Five mL of tetrahydrofuran (THF) was added and the 
mixture was vortexed. This mixture was allowed to stand at room temperature with intermittent 
vortexing for 30 minutes. Ten mL of extraction solvent (dichloromethane/petroleum 
ether/hexane, 2:4:4) containing 0.005% BHT was added, vortexed, and centrifuged at 800× g for 
15 min. After the upper layer was removed, 10 mL of extraction solvent was added to the bottom 
layer and the extraction process was repeated one more time. The extract was pooled and 
evaporated under nitrogen, followed by adding 3 mL deionized water and 3 mL ethanol. This 
mixture was vortexed, sonicated, and centrifuged at 800× g for 5 min at 4 °C. The upper layer 
was transferred and dried under nitrogen in a 40 °C water bath.  
 For plasma or serum analysis, about 250 μL sample was mixed with an equal volume of 
ethanol containing 0.1% BHT and then vortexed. One mL of hexane was added, vortexed, and 
centrifuged at 2400 g at 4°C (Centrifuge 5417R, Eppendorf, Hamburg, Germany) for 3 min. The 
upper hexane layer was removed. The hexane extraction process was repeated two more times. 
The extract was pooled and evaporated to dryness under argon. 
 For brain analysis, brain samples (0.15 g) were homogenized with 0.3 mL of 0.9% NaCl 
solution and 0.5 mL ethanol. 100μL of 0.8 μmol/L echinenone in ethanol (A1%1cm = 2244) was 
added to the homogenate as an internal standard. After incubating at 70°C for 2 min, 0.5 mL of 
freshly-prepared 25% sodium ascorbate and 1 mL of 5% NaOH were added. The mixture was 
saponified in a 60 °C water bath for 20 min. Then, 0.5 mL of distilled water was added and the 
mixture was placed on ice for 5 min. Five mL of hexane was added, and the mixture was 
vortexed for 2 min and centrifuged at 1000 × g at 4 °C (Centrifuge CR3, Jouan, Winchester, VA, 
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USA) for 10 min. The upper hexane layer was removed and the hexane extraction process was 
repeated two more times. The extract was pooled and evaporated to dryness under argon.  
 For retina analysis, the tissue was minced with 1 mL 0.85% saline by using a glass rod on 
ice. To this, 3 mL chloroform-methanol (2:1, v/v) and echinenone were added. After vortexing, 
the layers were separated by centrifugation at 800 × g at 4 °C (Centrifuge CR3, Jouan) for 15 
min. The lower chloroform layer was transferred and evaporated to dryness under argon. The 
extraction was repeated using 3 mL hexane. 
 For adipose tissue analysis, adipose sample (125mg) was homogenized with 400 μL PBS. 
Chloroform (500 μL) and 1 mL methanol were added and vortexed for 5 min. After 
centrifugation at 1200× g at 10 °C (Centrifuge CR3, Jouan) for 10 min, the lower phase was 
collected and evaporated to dryness under argon.  One mL of 5.5% KOH in ethanol and 100 μL 
of freshly prepared 1.2% pyrogallol in ethanol were added to the dry residue and vortexed. After 
incubation at 37 °C for 90 min for saponification, 1 mL distilled water, echinenone as an internal 
standard, and 3 mL hexane were added. Carotenoids were extracted by hexanes using the above-
described steps.  
 For other tissue (liver, quadriceps, kidney, heart, lungs, spleen, ovaries, and testes) 
analysis, samples were minced with ethanol containing 0.1% BHT, and 1 mL of 100% KOH 
saturated solution was added. After saponification in a 60 °C water bath with intermittent 
vortexing for 30 min, 2 mL of deionized water and 6 mL of hexanes were added. Carotenoids 
were extracted by hexanes using the above-described steps. 
 All analyses were carried out on an Alliance HPLC system (e2695 Separation Module) 
equipped with 2998 photodiode array detector (Waters, Milford, MA). The extracts were 
separated on a reverse-phase C 30 column (4.6 × 150 mm, 3 μm; YMC, Wilmington, NC) 
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maintained at 18°C. A phase gradient method used for carotenoid separation was based on the 
method of Yeum et al. (28). The lower limit of detection for carotenoids is 0.2 pmol. The average 
recovery of the internal standard was 92.8 ± 0.5%. Carotenoids were identified via absorption 
spectra, retention times, and standard comparison and quantified by an external standard curve 
method or internal standard curve method. Our laboratory regularly participates in the National 
Institutes of Standards in Technology micronutrient proficiency testing program for carotenoids 
and retinoids. 
Statistical Analysis 
 Data analyses were performed using SPSS (version 23; IBM SPSS Statistics) or SAS 
(version 9.4; SAS Institute Inc). Unequal variances were evaluated prior to ANOVA analysis 
using Levene’s test of homogeneity of variance. Changes in blood carotenoid concentrations, 
formula intake, body weight, and head circumference over time were analyzed by means of two-
way repeated-measures ANOVA. Two-way ANOVA was performed to assess effects of diet and 
brain region, diet and adipose region, or diet and sex on carotenoid concentrations. Carotenoid 
concentrations in multiple tissues were analyzed by using one-way ANOVA, with Bonferroni’s 
multiple comparison test. In case of unequal variances, the Welch’s ANOVA was used to 
compare group means, followed by Dunnett’s T3 test for posthoc comparisons. The relationships 
between pairs of variables were determined by linear regression analyses. All data are presented 
as mean ± SD. All differences or relationships were considered significant when P < 0.05. 
RESULTS 
Formula Intake, Body Weight and Organ Weights  
 Formula intake gradually increased with age through 6 months, and there were no 
significant differences in the consumed amount of formula between the two formula groups 
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(Figure 3.1A). No significant differences were found among dietary groups in body weight or its 
rate of increase with age (Figure 3.1B) or in head circumference (Figure 3.1C). In addition, no 
differences were observed among dietary groups for any organ weight except for modest changes 
for the liver (19% increase in the SF compared to the BF group, P = 0.014; 15% increase in the 
UF compared to the BF group, P = 0.071) and adrenal glands (28% increase in the UF formula 
compared to the BF group, P = 0.006).   
Carotenoid Profiles of Formula and Breast Milk  
 The carotenoid profiles of breast milk and the two infant formulas are shown in Table 
3.2. We analyzed milk samples collected from six of the breastfeeding dams at 2 to 4 time points 
each from 2 to 6 months after birth. Lutein and zeaxanthin concentrations in breast milk were 
1.1-fold and 5.5-fold higher, respectively, than in the supplemented formula. The supplemented 
formula contained higher amounts of lutein, zeaxanthin, and β-carotene (6.1-fold, 8.5-fold, and 
3.5-fold, respectively) than the unsupplemented formula. Lycopene was present in the 
supplemented formula but undetectable in the unsupplemented formula or in breast milk. β-
carotene and β-cryptoxanthin were undetectable in breast milk. It is possible that these 
carotenoids were not detected, despite their presence at low concentrations in serum and tissues 
of BF infants, due to the small volumes (100-1000 μl) of breast milk available for carotenoid 
analysis. 
Plasma/Serum Carotenoids 
 Blood carotenoid concentrations are shown in Figure 3.2. At baseline, dietary groups did 
not differ in the concentrations of lutein and zeaxanthin. Lycopene was undetectable at baseline 
in any animal. Blood lutein concentrations increased from baseline in the BF and SF groups, but 
not the UF group (Figure 3.2A). Breastfeeding significantly increased blood lutein 
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concentrations compared to both formula groups. In the formula-fed groups, after 6 months of SF 
feeding, blood lutein concentrations were 5-fold higher than in the UF group animals (P < 
0.001), but still 5-fold lower than in BF infants. Blood zeaxanthin concentrations increased from 
baseline only in the BF group and were undetectable in the UF group after week 4 and in the SF 
group after week 12 (Figure 3.2B). Blood lycopene was detected throughout the feeding period 
only in the SF group (Figure 3.2C). In the BF group, a few infants had measurable blood 
lycopene at weeks 16 (3 infants) and 25 (1 infant), possibly because a lycopene-rich fruit or 
vegetable was temporarily included in the maternal diet. Blood β-carotene concentrations 
increased from baseline in all groups; significantly higher concentrations were found in the BF 
group compared to the formula-fed groups after week 4, with no significant differences between 
the formula groups at week 25 (Figure 3.2D). Blood β-cryptoxanthin concentrations increased 
from baseline only in the BF group and were undetectable in the formula-fed groups after week 4 
(data not shown). No significant sex or diet-by-sex interaction effects were observed for any 
blood carotenoid concentrations at any individual time point (data not shown).   
Brain Carotenoids 
 Lutein, zeaxanthin, and β-carotene concentrations in nine different brain regions 
(prefrontal cortex, occipital cortex, superior temporal cortex, striatum, cerebellum, motor cortex, 
gray matter, white matter, and hippocampus) are presented in Figure 3.3. Lutein accumulation 
differed among brain regions, with the highest amount in occipital cortex across all diet groups. 
In all brain regions analyzed, breastfeeding significantly increased lutein concentrations 
compared to either formula group; the SF group showed significantly higher lutein deposition 
compared to the UF group. A two-way ANOVA supported these observations, with significant 
main effects of brain region (P < 0.001) and diet (P < 0.001), as well as a significant diet × brain 
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region interaction (P < 0.001); post-hoc pair-wise comparisons confirmed significant differences 
among all three groups in each brain region. Similarly to lutein, zeaxanthin selectively 
accumulated across brain regions, also with the highest amount in occipital cortex, but was 
detectable only in the BF group. There was a strong correlation between lutein and zeaxanthin 
concentrations in the brain regions of the BF group (r = 0.954, P < 0.001), suggesting that lutein 
and zeaxanthin may share the same uptake mechanisms into the brain.  
 Small amounts of β-carotene (range: 8-21 pmol/g) were detected in all brain regions of all 
groups. The BF group had significantly higher β-carotene concentrations in all brain regions 
except the hippocampus, but only striatum and motor cortex reached statistical significance. A 
two-way ANOVA showed significant main effects of brain region (P = 0.001) and diet (P = 
0.004) as well as a significant diet × brain region interaction (P = 0.019). In pairwise 
comparisons, the SF group had significantly higher concentrations of β-carotene than the UF 
group in only one brain region, the cerebellum. Lycopene was not detected in any brain region, 
despite the high lycopene content in the supplemented formula.   
 No significant effects of sex or diet-by-sex interactions were seen in brain lutein and 
zeaxanthin concentrations in any brain region (data not shown). A significant sex difference in 
brain β-carotene concentrations was found only in gray matter and hippocampus, with 
concentrations higher in males than in females (P = 0.018 and P = 0.027, respectively).   
  Strong positive correlations were found between concentrations of lutein in 25-week 
serum samples and in each brain region, as shown in Table 3.3 (R2 = 0.71-0.87, P < 0.001). 
Among the nine brain regions, the slope (β) of the regression line was highest in occipital cortex 
and lowest in cerebellum, suggesting preferential uptake and lower lutein metabolism in the 
occipital cortex, and vice versa in the cerebellum. β-carotene concentrations in serum and each 
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brain region generally were more weakly correlated. The slope for serum versus brain β-carotene 
was lower than that of lutein in all brain regions, suggesting a selective lutein uptake mechanism 
from blood into the brain, or differential β-carotene metabolism in brain.   
Retinal Carotenoids 
 Lutein and zeaxanthin concentrations were higher in the macular retina (4 mm diameter 
central sample) or than in the peripheral retina (Figure 3.4). BF monkeys had significantly 
higher lutein and zeaxanthin concentrations in both retinal regions than both formula-fed groups. 
Carotenoid supplementation of formula significantly increased lutein concentrations in the 
peripheral retina but not in the macular retina. In contrast, zeaxanthin concentrations did not 
differ between formula groups in either retinal region.  
 Lutein concentrations were positively correlated between 25-week serum and each retinal 
region, as shown in Table 3.3 (R2 = 0.76 for macular retina; R2 = 0.90 for peripheral retina, P < 
0.001). The slope of the regression line was higher in macular retina than in peripheral retina. In 
addition, strong correlations were found between lutein concentrations in both retina and brain 
regions (Table 3.3; R2 = 0.54 - 0.72, P < 0.001).  
Adipose Tissue Carotenoids 
 Carotenoid concentrations varied among the four adipose sites examined (Table 3.4). A 
two-way ANOVA found a significant main effect of diet (P < 0.001), but not of adipose region 
(P = 0.307), nor a diet × adipose region interaction (P = 0.627). The BF group had the 
significantly higher lutein concentrations in all adipose tissues except BAT compared with the 
formula-fed groups. SF significantly increased lutein accumulation in all adipose regions except 
TSAT, where a similar trend was observed.  
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 SF significantly increased β-carotene concentrations in all adipose regions compared with 
the UF group. Zeaxanthin was detectable in all adipose regions of BF infants and in TSAT of one 
monkey fed SF. Lycopene was detectable in all adipose regions of the SF group, but not in the 
BF or UF groups. β-cryptoxanthin in all adipose regions was detectable only in the BF group 
(data not shown). No significant sex difference or diet x sex interaction was observed in the 
concentrations of any of the carotenoids in any adipose region.   
Carotenoids in Other Tissues 
 Lutein, zeaxanthin, β-carotene, and total lycopene concentrations in the liver, quadriceps, 
kidney, heart, lungs, spleen, ovaries, and testes are presented in Table 3.5. Lutein concentrations 
in these tissues were higher in the BF group than in the formula-fed groups and lower in the UF 
group than in the SF group. In the liver, lutein was the predominant carotenoid. The BF group 
showed 5-fold and 24-fold increases in liver lutein concentrations compared with the SF and the 
UF groups, respectively, whereas a 5-fold difference was seen between the SF and UF groups. 
Zeaxanthin was detected in all tissues from BF monkeys. In contrast, in the SF group, zeaxanthin 
was undetectable in the quadriceps, heart, and ovaries, but present in the lungs, kidney, and testes 
from only one monkey; and in the UF group, it was undetectable in the liver, quadriceps, kidney, 
lungs, spleen, ovaries, and testes, and detected in the heart of only one monkey. β-Carotene 
concentrations were significantly higher in the BF group in all tissues except the liver compared 
to the formula-fed groups. Formula supplementation enhanced β-carotene concentrations in the 
liver, kidney, heart, lungs, spleen, ovaries, and testes compared to UF but was not generally 
detected in other organs of the UF group. Lycopene was detectable in all tissues of the SF group, 
but in none of the UF group, with the exception of the liver of 1 subject. In BF monkeys, 
lycopene was present in a few individuals in some tissues. In addition, β-cryptoxanthin was 
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detectable in all tissues only in the BF group (data not shown). No significant sex difference or 
diet-by-sex interaction was found for any carotenoid in any of the tissues.   
DISCUSSION 
 This study compares the effects of breastfeeding and infant formula-feeding on lutein 
bioaccumulation in multiple tissues of nonhuman primate infants during the first six months of 
life. Our earlier study in infant rhesus macaques at 1 to 3 months of age described the diet-
dependent patterns of tissue lutein deposition resulting from 4 months of feeding infant formulas 
containing high and low concentrations of carotenoids (27). However, that pilot study had a 
small sample size (n = 2/group), did not initiate formula feeding at birth, and lacked a breastfed 
control group. The current study demonstrates in greater detail the unique bioaccumulation 
patterns of carotenoids including lutein in infant monkeys in response to breast milk and infant 
formulas.  
 Breast milk is a preferred dietary vehicle to deliver carotenoids, especially lutein, to 
serum and tissues compared to either infant formula. Serum and all tissues examined in this 
study showed higher lutein deposition following breastfeeding compared to the formula-fed 
groups, despite the similar lutein concentrations in breast milk and the supplemented formula. 
Previously, the bioavailability of lutein from breast milk and infant formula were compared in 
human infants and was found to be about four times greater from breast milk, as assessed by 
serum lutein concentrations (26). This result is in line with an in vitro study using human 
intestinal cell lines, which showed that the higher lutein bioavailability of breast milk was 
primarily due to enhanced intestinal absorptive processes compared to infant formula (29). 
Zeaxanthin was undetectable in the brain of formula-fed infant monkeys but present in all brain 
regions of the BF monkeys; in this case the difference may be due to both a higher zeaxanthin 
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concentration in breast milk and its higher bioavailability. There are many potential factors that 
may be responsible for enhanced carotenoid bioavailability from breast milk including food 
matrix, fat content, and nutrient-nutrient interactions (30, 31).   
 We found that breast milk enhanced lutein and zeaxanthin accumulation in both macular 
and peripheral retina compared to either formula, but interestingly in the macular region 
accumulation was not increased by formula supplementation. Lutein and zeaxanthin have unique 
roles as the components of macular pigment and thus in tissue protection and enhancement of 
foveal vision. Therefore, enhanced macular lutein deposition from breast milk may lead to 
optimal retinal function with possible consequences throughout the lifespan. In contrast, lutein 
deposition in all other tissues was increased by formula supplementation, in agreement with our 
pilot study results (27). The enhanced lutein accumulation in macular retina by breast milk 
implies a highly targeted mechanism by which xanthophylls are efficiently delivered and 
concentrated in this specific location. Although both lutein and zeaxanthin are found primarily in 
HDL, Thomas et al. (32) recently reported that zeaxanthin was selectively taken up via an HDL-
mediated SR-B1 pathway, while LDL more efficiently delivered lutein for entry into the retina. 
Furthermore, lutein is protected by binding to a specific lutein binding protein, steroidogenic 
acute regulatory domain protein 3 (StARD3) (33). The effect of diet on xanthophyll uptake, as 
well as xanthophylls’ protective mechanisms and lifelong impact, requires further study.  
 We confirmed the differential lutein accumulation across brain regions of infant 
monkeys, with highest concentrations in occipital cortex, the site of the primary visual cortex, in 
all diet groups. This distribution may imply a distinctive role of lutein in the visual system. 
Lutein supplementation has been reported to enhance aspects of visual processing speed that are 
believed to reflect visual cortical processing (14). In addition, we found the lowest amount of 
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lutein in cerebellum of the BF and SF groups, but not the UF group. This result is in agreement 
with results in adult rhesus macaques, in which lower lutein accumulation was observed in 
cerebellum compared to concentrations in the striatum, occipital, frontal, or prefrontal cortices 
(25, 34). However, in human centenarians, greater lutein was deposited in the cerebellum 
compared to multiple cortical areas (18), a discrepancy that may be linked to age-related or 
pathologic cognitive decline. The unique pattern of lutein bioaccumulation may result from 
different lutein uptake, transport, or metabolism among brain regions.  
 A novel finding was that lycopene was undetectable in any brain region despite 
significant accumulation in serum and tissues of the SF group. This is interesting, considering 
that the SF had a higher content of lycopene than β-carotene, and some β-carotene did 
accumulate in the brain of the SF-fed infants. Thus, it may be assumed that there is a selective 
uptake mechanism for β-carotene and xanthophylls but not for lycopene. The absence of 
lycopene in brain is consistent with a study in deceased human infants showing that lycopene 
was detected only in 3 of the 30 decedents, while lutein, zeaxanthin, cryptoxanthin, and β-
carotene all were detectable (16). Interestingly, a small amount of lycopene accumulated in the 
brains of older adults, although less than β-carotene (18). In addition, it was reported that 
lycopene accumulated in the brains of wild-type and β-carotene 15,15′-oxygenase (BCO1) 
knockout mice fed lycopene-containing diets (35). The existence of lycopene in brain may differ 
as a function of age and species, as a function of chronic lycopene consumption or due to altered 
blood brain barrier function during ageing. 
 Our study showed that both lutein and zeaxanthin were most highly concentrated in the 
macular retina, followed by liver. β-carotene and total lycopene accumulation patterns differed 
from those of xanthophylls. The highest β-carotene concentrations were found in adipose tissues 
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and the second highest in the liver and spleen, with little in brain. In all but two of the SF-fed 
monkeys, lycopene was most concentrated in adipose tissue, followed by liver. This differential 
carotenoid accumulation may be due to the different polarities of non-hydroxylated carotenes 
and polar hydroxylated xanthophylls (36). Moreover, the accumulation pattern might be affected 
by carotenoid-carotenoid interactions (31).     
 This study is significant in that it demonstrates lutein tissue accumulation in early life, 
during a critical period for retinal and neural development. One of the study’s strengths was in 
the utilization of an appropriate animal model, rhesus macaques. One limitation of this study was 
that we were unable to investigate the potential molecular mechanisms underlying the unique 
carotenoid bioaccumulation patterns; this objective was beyond the scope of the current study.  
 In conclusion, we demonstrated that breastfeeding infant rhesus macaques had enhanced 
serum and tissue lutein concentrations compared to formula-fed animals. Lutein concentrations 
in the SF group exceeded those in the UF group, but were still several-fold less than in BF 
infants. We confirmed that there is differential lutein accumulation across brain regions and that 
the occipital cortex accumulates the highest amounts of lutein, suggesting that lutein may have a 
critical role in visual processing in early life. 
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TABLES AND FIGURES 
Table 3.1 Summary of infant rhesus macaques characteristics 
  BF SF UF Total 
  (n=8) (n=8) (n=7) (n=23) 
Gender Female/Male 4/4 4/4 4/3 12/11 
Age (days) at sacrifice Mean ± SD 179 ± 4  178 ± 3 178 ± 3 178 ± 3 
Birth weight (kg) Mean ± SD 0.50 ± 0.05 0.49 ± 0.05 0.52 ± 0.06 0.50 ± 0.05 
Final weight (kg) Mean ± SD 1.41 ± 0.12 1.40 ± 0.10 1.47 ± 0.10 1.43 ± 0.11 




Table 3.2 Carotenoid profiles of rhesus macaques breast milk and infant formulas1. 
 BF SF UF 
Lutein (nmol/kg) 251 ± 113 237 ± 14.5 38.6 ± 15.4 
Zeaxanthin (nmol/kg) 105 ± 46.1 19.0 ± 2.4 2.3 ± 1.1 
β-carotene (nmol/kg) ND2 74.2 ± 17.1 21.5 ± 9.4 
Total lycopene 
(nmol/kg) 
ND 338 ± 25.1 ND 
β-cryptoxanthin 
(nmol/kg) 
ND ND ND 
1Values are means ± SD. 2ND: not detected. BF: breastfed; SF: supplemented formula-fed; UF: 
unsupplemented formula-fed 
2Data obtained from 2-3 batches of infant formula and breast milk samples collected from 8 




Table 3.3 Results of simple linear regression analyses with 25-week serum lutein, serum β-
carotene (nmol/L), or retinal lutein (pmol/g) concentrations as independent variables and brain 
lutein, retinal lutein, or β-carotene concentrations (pmol/g) as dependent variables (n=23) 
Independent 
variable 
Dependent variable β (95% CI) R2 P value 
Lutein 
Serum Prefrontal cortex 0.38 (0.30, 0.45) 0.82 < 0.001 
Occipital cortex 0.63 (0.50, 0.76)  0.84 < 0.001 
Superior temporal cortex 0.32 (0.23, 0.40) 0.75 < 0.001 
Striatum 0.45 (0.34, 0.56) 0.78 < 0.001 
Cerebellum 0.19 (0.16, 0.22) 0.87 < 0.001 
Motor cortex 0.38 (0.27, 0.49) 0.71 < 0.001 
Gray matter 0.33 (0.27, 0.39) 0.86 < 0.001 
White matter 0.26 (0.20, 0.33) 0.79 < 0.001 
Hippocampus 0.24 (0.19, 0.28) 0.85 < 0.001 
Macular retina 11.7 (8.72, 14.8) 0.76 < 0.001 
Peripheral retina 2.24 (1.90, 2.58)  0.90 < 0.001 
Macular retina Prefrontal cortex 0.02 (0.02, 0.03) 0.64 < 0.001 
Occipital cortex 0.04 (0.02, 0.05) 0.59 < 0.001 
Superior temporal cortex 0.02 (0.01, 0.03) 0.55 < 0.001 
Striatum 0.03 (0.02, 0.04) 0.54 < 0.001 
Cerebellum 0.01 (0.01, 0.02) 0.68 < 0.001 
Motor cortex 0.02 (0.02, 0.03) 0.57 < 0.001 
Gray matter 0.02 (0.01, 0.03) 0.64 < 0.001 
White matter 0.02 (0.01, 0.02) 0.61 < 0.001 
Hippocampus 0.01 (0.01, 0.02) 0.58 < 0.001 
Peripheral 
retina 
Prefrontal cortex 0.14 (0.09, 0.19)  0.65 < 0.001 
Occipital cortex 0.24 (0.16, 0.32) 0.68 < 0.001 
Superior temporal cortex 0.12 (0.07, 0.16) 0.58 < 0.001 
Striatum 0.17 (0.11, 0.23) 0.64 < 0.001 
Cerebellum 0.07 (0.05, 0.09) 0.72 < 0.001 
Motor cortex 0.14 (0.08, 0.20) 0.55 < 0.001 
Gray matter 0.13 (0.09, 0.16) 0.69 < 0.001 
White matter 0.10 (0.07, 0.14) 0.63 < 0.001 





Table 3.3 (cont.) 
β-carotene 
Serum Prefrontal cortex 0.03 (0.01, 0.04) 0.30 0.01 
Occipital cortex 0.03 (0.02, 0.05) 0.43 0.001 
Superior temporal cortex 0.02 (0.00, 0.04) 0.25 0.02 
Striatum 0.04 (0.02, 0.06) 0.41 0.001 
Cerebellum 0.02 (0.00, 0.03) 0.26 0. 01 
Motor cortex 0.03 (0.02, 0.05) 0.57 < 0.001 
Gray matter 0.02 (0.00, 0.03) 0.16 0.06 
White matter 0.04 (0.01, 0.06) 0.31 0.01 




Table 3.4 Carotenoid concentrations in infant rhesus macaques in each adipose region1.  
1 ND: not detected. 
Abdominal 
area 
Dietary group P values 






ASAT 643 ± 405a 102 ± 44.9b 26.5 ± 22.7c 
< 0.001 0.307 0.627 
TSAT 545 ± 370a 88.8 ± 77.9b 22.6 ± 26.6b 
MAT 403 ± 277a 69.7 ± 34.7b 8.6 ± 10.6c 
BAT 402 ± 427a 48.6 ± 20.1a 7.7 ± 9.7b 
Zeaxanthin (pmol/g) 
ASAT 163 ± 102 ND2 ND 
- - - 
TSAT 146 ± 97.5a 2.0 ± 5.6b  ND 
MAT 100 ± 69.7 ND ND 
BAT 97.2 ± 101 ND ND 
β-carotene (pmol/g) 
ASAT 159 ± 26.7a 172 ± 136a 48.4 ± 26.1b 
0.002 0.001 0.021 
TSAT 157 ± 43.3a 147 ± 89.0a 42.5 ± 26.2b 
MAT 118 ± 54.9a 102 ± 41.9a 36.0 ± 18.2b 
BAT 117 ± 54.6ab 167 ± 78.4a 48.4 ± 27.3b 
Total lycopene (pmol/g) 
ASAT ND 366 ± 107 ND 
- - - 
TSAT ND 287 ± 57.1 ND 
MAT ND 209 ± 40.4 ND 
BAT ND 293 ± 58.1 ND 
1Values are means ± SD (n=7-8/ group). 2ND: not detected. The lower limit of detection for carotenoids is 
1.6 pmol/g. Diet and area effects were determined by two-way ANOVA. Values in a row with different 
superscript letters are significantly different, P < 0.05 by one-way ANOVA or Welch’s test followed by 
Bonferroni or Dunnett’s T3 pairwise posthoc tests. BF: breastfed; SF: supplemented formula-fed; UF: 
unsupplemented formula-fed; ASAT: abdominal subcutaneous adipose tissue; MAT: mesenteric adipose 









BF SF UF 
Liver 
Lutein 2680 ± 1008a 530 ± 89.6b 114 ± 88.1c 
Zeaxanthin 1071 ± 380a 42.8 ± 28.7b ND2 
β-carotene 151 ± 137a 65.9 ± 29.2ab 8.9 ± 15.2b 
Total lycopene 2.0 ± 5.6b 224 ± 80.5a 8.2 ± 21.6b 
Quadriceps 
Lutein 148 ± 67.0a 24.7 ± 4.0b 2.4 ± 4.2c 
Zeaxanthin 49.0 ± 30.6 ND ND 
β-carotene 17.4 ± 15.7 ND ND 
Total lycopene 4.9 ± 13.9 16.1 ± 11.6 ND 
Kidney 
Lutein 273 ± 110a 39.8 ± 7.5b 16.2 ± 18.9c 
Zeaxanthin 91.5 ± 35.0a 1.3 ± 3.6b ND 
β-carotene 45.2 ± 14.7 28.6 ± 12.2 ND 
Total lycopene ND 53.6 ± 4.0 ND 
Heart 
Lutein 189 ± 67.8a 31.7 ± 3.6b 19.3 ± 39.5b 
Zeaxanthin 69.6 ± 25.6a ND 1.4 ± 3.8b 
β-carotene 43.7 ± 11.3 a 22.0 ± 13.7b ND 
Total lycopene 7.0 ± 19.7b 31.4 ± 15.1a ND 
Lungs 
Lutein 536 ± 248a 152 ± 192b 21.6 ± 10.8b 
Zeaxanthin 230 ± 104a 1.1 ± 3.1b ND 
β-carotene 73.4 ± 23.8a 36.5 ± 16.3b 1.9 ± 5.0c 
Total lycopene ND 62.3 ± 17.8 ND 
Spleen 
Lutein  1008 ± 386a 199 ± 47.8b 41.3 ± 20.7c 
Zeaxanthin 367 ± 148a 15.5 ± 6.9b ND 
β-carotene 134 ± 63.4a 56.9 ± 23.5b 8.8 ± 15.0c 
Total lycopene 2.0 ± 5.6b 117.1 ± 35.2a ND 
Ovaries 
Lutein 600 ± 271a 110 ± 12.9b ND 
Zeaxanthin 233 ± 100 ND ND 
β-carotene 76.3 ± 44.9 68.6 ± 44.9 ND 
Total lycopene 17.0 ± 34.0b 114 ± 81.4a ND 
Testes 
Lutein 419 ± 171a 77.3 ± 19.9b 15.5 ± 19.9b 
Zeaxanthin 171 ± 72.9a 3.4 ± 6.8b ND 
β-carotene 59.7 ± 23.2 23.6 ± 18.1 ND 
Total lycopene ND 69.9 ± 6.8 ND 
1Values are means ± SD (n=7-8/ group, n=3-4/ group for ovaries and testes).  2ND: not detected. 
The lower limit of detection for carotenoids is 2 pmol/g. Values in a row with different 
superscript letters are significantly different, P < 0.05 by one-way ANOVA or Welch’s test 
followed by Bonferroni or Dunnett’s T3 pairwise posthoc tests. BF: breastfed; SF: supplemented 




Figure 3.1 The amount of infant formula consumed per week by infant monkeys fed the two 
infant formulas for 6 months. Body weight (B) and head circumference (C) of infant rhesus 
monkeys either breastfed (BF, n=8), fed supplemented formula (SF, n=8), or unsupplemented 
formula (UF, n=7) for 6 months. Values are presented as mean ± SD. No significant group 





Figure 3.2 Plasma/serum lutein (A), zeaxanthin (B), total lycopene (C), and β-carotene (D) in 
infant rhesus monkeys either breastfed (BF, n=8), fed supplemented formula (SF, n=8), or 
unsupplemented formula (UF, n=7) for 6 months. Values are presented as mean ± SD. Diet and 
age effects were determined by two-way repeated measures ANOVA. Labeled means at each 
time point without a common letter differ, P < 0.05, by one-way ANOVA followed by 






Figure 3.3 Lutein (A), zeaxanthin (B), and β-carotene (C) concentrations in each brain region of 
infant monkeys either breastfed (BF, n=8), fed supplemented formula (SF, n=8), or 
unsupplemented formula (UF, n=7) for 6 months. Values are presented as mean ± SD. Diet and 
area effects were determined by two-way ANOVA. Labeled means for each tissue without a 
common letter differ, P < 0.05, by one-way ANOVA or Welch’s test followed by Bonferroni or 
Dunnett’s T3 pairwise posthoc tests. ND: not detected. The lower limit of detection for 
carotenoids is 0.2 pmol. PFC: prefrontal cortex; OC: occipital cortex; STC: superior temporal 






Figure 3.4 Lutein (A) and zeaxanthin (B) levels in each retina region of infant rhesus monkeys 
either breastfed (BF, n=8), fed supplemented formula (SF, n=8), or unsupplemented formula 
(UF, n=7) for 6 months. Values are means ± SD. Labeled means for each tissue without a 
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CHAPTER 4:  
Relationships of Carotenoid-Related Gene Expression and Serum Cholesterol and 
Lipoprotein Levels to Retina and Brain Lutein Deposition in Infant Rhesus Macaques 
Following 6 Months of Breast Feeding or Formula Feeding12 
 
ABSTRACT 
 The purpose of this study was to investigate if the enhanced bioaccumulation of lutein in 
retina and brain of breastfed, compared to formula-fed, infant monkeys was associated with 
higher levels of serum total and HDL cholesterol, apolipoproteins, or mRNA/protein expression 
of carotenoid-related genes. Newborn rhesus macaques were either breastfed, fed a carotenoid-
supplemented formula, or fed an unsupplemented formula for 6 months (n = 8, 8, 7). Real-time 
qPCR and western blotting were performed in two brain regions (occipital cortex and 
cerebellum) and two retina regions (macular and peripheral retina). Breastfed infants had higher 
serum total cholesterol, HDL cholesterol, apoA-I, and apoB-100 levels than the combined 
formula-fed groups (P<0.05). Breast milk or infant formulas did not alter expression of the nine 
genes (CD36, SCARB1, SCARB2, LDLR, STARD3, GSTP1, BCO1, BCO2, RPE65) examined 
except for SCARB2 in the retina and brain regions. In conclusion, dietary regimen did not impact 
the expression of carotenoid-related genes except for SCARB2. However, carotenoid-related 
                                                 
1This chapter was the result of a collaboration of the following authors: Sookyoung Jeon, Martha 
Neuringer, Matthew J. Kuchan, and John W. Erdman, Jr. 
2Reproduced with permission from Jeon S, Neuringer M, Kuchan MJ, Erdman JW Jr. 
Relationships of carotenoid-related gene expression and serum cholesterol and lipoprotein levels 
to retina and brain lutein deposition in infant rhesus macaques following 6 months of breast 
feeding or formula feeding, Arch Biochem Biophys, S0003-9861(18)30161-9. Copyright 2018. 
95 
 
genes were differentially expressed across brain and retina regions. Breastfed infants had higher 
serum total and HDL cholesterol, and apolipoproteins, suggesting that lipoprotein levels might 
be important for delivering lutein to tissues, especially the macular retina, during infancy. 
 
INTRODUCTION 
 Humans are not able to synthesize lutein, a yellow xanthophyll, de novo. Therefore, 
tissue deposition of lutein is dependent upon dietary sources, such as green leafy vegetables, 
fruits, and egg yolks. Lutein is distributed ubiquitously in tissues; most notably, lutein selectively 
accumulates in the retina and brain. Lutein and its isomers zeaxanthin and meso-zeaxanthin 
constitute macular pigment in the primate fovea, where they have an essential role in eye health 
and visual performance (1). Dietary consumption of lutein and zeaxanthin is associated with a 
decreased risk of age-related macular degeneration (AMD), a leading cause of visual loss in the 
elderly (2, 3). In addition, lutein preferentially accumulates in the neural tissues of infants and 
older adults (4-6), which implicates a lutein’s role in brain function. Moreover, there is 
accumulating evidence showing the associations between lutein intake or retinal deposition and 
enhanced cognitive function across life stages (7-10)  
 Various factors involved in lutein’s selective accumulation in the retina have been widely 
studied. In circulation, polar xanthophylls are transported mainly by HDL particles compared to 
the hydrophobic carotenes (11). Lutein is taken up into the retina from circulation via several 
receptors including CD36 and class B scavenger receptors (SR-B1 and SR-B2) (12). In retina 
tissue, steroidogenic acute regulatory domain protein 3 (STARD3) selectively binds and protects 
lutein (13) while glutathione S-transferase P1 (GSTP1) binds zeaxanthin (14). β-Carotene 9’,10’ 
oxygenase (BCO2), along with β-carotene-15,15’-oxygenase (BCO1), are known mammalian 
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carotenoid cleavage enzymes. Human BCO1 appears to be the primary enzyme to cleave 
carotenes (15). BCO2 isolated from ferret and chicken cleaves a variety of carotenoids including 
xanthophylls (16, 17). Interestingly, Li et al. (18) suggested that the inactivity of primate BCO2 
due to the loss of an alternative splicing site contributes to selective accumulation of lutein and 
zeaxanthin in primate retina. In contrast, Babino et al. (19) proposed that the enzymatic function 
of human BCO2 is conserved and BCO2 expression is regulated by oxidative stress. Recently it 
was discovered that RPE65, known as retinoid isomerase, can convert lutein to meso-zeaxanthin 
in vertebrate eyes (20). Furthermore, it has been shown that multiple single nucleotide 
polymorphisms (SNPs) in genes related to lutein absorption, transport, and metabolism are 
associated with macular pigment optical density (MPOD), and also may be related to the risk of 
AMD (21). In the brain, the mechanism for lutein accumulation is not well understood, but it is 
assumed to be similar to retina, as the blood-brain barrier and blood-retina barrier are structurally 
and functionally similar. In addition, brain lutein concentrations and MPOD are highly correlated 
in primates (22, 23).  
 In early life, infants are dependent upon lutein intake from breast milk and/or infant 
formula. Recently, we compared the influence of breast milk, a carotenoid-supplemented 
formula or an unsupplemented formula on lutein biodistribution patterns in tissues of infant 
rhesus macaques after 6 months of life (24). Breastfed infants accumulated significantly more 
lutein in all tissues examined than those fed the carotenoid-supplemented formula despite similar 
lutein levels in each. It is likely that the macronutrient matrix of breast milk enhances carotenoid 
bioavailability compared to commercial formulas (24, 25). However, we speculate that in 
addition to the differences in lutein bioavailability between breast and formula milk, differential 
expression of carotenoid-related genes might explain a portion of the differences in lutein 
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accumulation in brain and retina between the diet groups. We probed whether breast milk or 
formulas high and low in carotenoids, fed to infant monkeys from birth to six months, 
differentially impacted 1) serum levels of total or HDL cholesterol or apolipoprotein and 2) the 
expression of transporters, binding proteins, and carotenoid cleavage enzymes in retina and 
selected brain regions.  
MATERIALS AND METHODS  
Animals and Diets  
 The procedures in this study were approved by the Institutional Animal Care and Use 
Committee of Oregon Health and Science University and were conducted in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. From the day 
after birth until 6 months, newborn rhesus macaques (Macaca mulatta) were either breastfed 
(n=8), fed a carotenoid-supplemented formula (n=8) (Similac Advance with OptiGRO), or fed an 
unsupplemented formula (n=7) based on the Similac Advance base formulation, with only the 
native carotenoids present in the lipid components. Based on our analysis by reverse-phase 
HPLC, lutein, zeaxanthin, β-carotene and lycopene, respectively, were found at the following 
levels in breast milk: 251, 105, 0, and 0 nmol/kg; supplemented formula: 237, 19.0, 74.2, and 
338 nmol/kg; and unsupplemented formula: 38.6, 2.3, 21.5, and 0 nmol/kg (24).  The 
breastfeeding dams were fed Monkey Diet Jumbo 5037 (Lab Diet) and fresh fruits and 
vegetables.  
 After 6 months of feeding, infant monkeys were humanely euthanized by a veterinary 
pathologist under deep pentobarbital anesthesia. At the time of death, fasting blood samples were 
collected and centrifuged at 800 × g for 15 min to obtain serum. From the brain, samples were 
dissected from occipital cortex (OC) and cerebellum (CB) and preserved in RNAlaterTM solution. 
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From each retina, 4 mm diameter biopsy punches were used to obtain samples of the macular 
(MR) and peripheral retina (PR). Once the vitreous was removed, the neural retina was dissected 
from the underlying retinal pigment epithelium and choroid. All collected samples were frozen in 
liquid nitrogen and then stored at -80° C until analysis. 
Carotenoid Analysis in Serum HDL and non-HDL Particles  
 All extractions and analyses were performed under yellow light to minimize light-
induced damage of carotenoids. Carotenoids in serum HDL and non-HDL particles were 
analyzed as follows. Briefly, 200 μL of serum was mixed with 500 μL of precipitation solution 
(0.44 mM phosphotungstic acid, 20 mM MgCl2) and 2 μL of 0.52 M pyrogallol. After vortexing, 
the mixture was incubated at room temperature for 15 minutes and then centrifuged at 2300 x g 
for 15 min at 4⁰C. After centrifugation, the supernatant was removed to obtain HDL-containing 
serum. For analyzing carotenoids in non-HDL particles, the pellet was mixed with 200 μL of 
0.85% saline, vortexed, and sonicated. Saline (0.85%, 2mL), echinenone as an internal standard, 
chloroform/ methanol (2:1, v/v) and 2 μL 0.52 M pyrogallol were added and vortexed. For 
analyzing carotenoids in HDL particles, 1.5 mL 0.85% saline and 100 µL internal standard were 
added to the isolated HDL-containing supernantant (300 µL), and then 9mL of 
chloroform/methanol (9 mL, 2:1 v/v) and 2 µL 0.52 M pyrogallol were added and vortexed. For 
both extractions, mixtures were centrifuged at 1000 g for 10 min at 4⁰C. The upper aqueous 
layer was transferred and the hexane extraction process was repeated two more times.  
 Carotenoid analyses were carried out on an Alliance HPLC system (e2695 Separation 
Module) equipped with 2998 photodiode array detector (Waters). The extracts were separated on 
a reverse-phase C30 column (4.6 × 150 mm, 3 μm; YMC) maintained at 18°C. A phase gradient 
method was used for carotenoid separation, based on the method of Yeum et al. (26). The lower 
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limit of detection for carotenoids was 0.2 pmol. The average recovery of the internal standard 
was 92.4 ± 1.0 %. Carotenoids were identified via absorption spectra, retention times, and 
comparison to standards and quantified by an internal standard curve method.  
Total Cholesterol, HDL Cholesterol, and Apolipoprotein Analyses  
 Serum total cholesterol levels were determined with a commercial kit (Wako 
Diagnostics) according to the manufacturer’s protocol. HDL cholesterol levels were analyzed in 
the isolated HDL-containing serum using the same kit. Serum apolipoprotein (apo) A-I, B-48, 
and B-100 levels were assessed with commercial ELISA kits (MyBioSource) according to the 
manufacturer’s instructions.  
Total RNA Extraction and Quantitative Real-time PCR Analysis  
 Total RNA was isolated from macular and peripheral regions of retinal pigment 
epithelium (RPE)–choroid and retina and from brain regions (OC and CB) using RNeasy® Lipid 
Tissue Mini Kit (Qiagen), according to the manufacturer’s instructions. cDNA was synthesized 
from 400ng of total RNA using RT2 First Strand Kit (Qiagen). RNA purity and concentrations 
were determined using a μCuvette G1.0 (Eppendorf) in a BioPhotometer (Eppendorf). 
Amplification reactions were performed on the QuantStudio™ 7 Flex Real-Time PCR System 
(Life Technologies) following the manufacturer’s protocol for the SYBR® Green ROX qPCR 
Mastermix (Qiagen). After testing three different reference genes [actin gamma 1 (ACTG1), 
ribosomal protein L13a (RPL13a), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)], 
ACTG1 was chosen as a reference gene because it had the lowest variability among different 
regions of brain, RPE–choroid, and retina samples. Relative gene expression levels were 




 Total proteins from frozen brain samples were extracted with RIPA buffer (Thermo 
Scientific) containing 1% protease inhibitor cocktail (Sigma) at 4°C. Protein concentrations were 
determined by the Pierce BCA protein assay kit (Thermo Fisher Scientific). 20 μg of proteins 
were separated on SDS-PAGE and transferred onto an Immobilon-P PVDF membrane 
(Millipore). Following blocking with 5% non-fat milk, membranes were probed with specific 
primary antibodies and subsequently incubated with HRP-linked secondary antibodies for 
chemiluminescent detection. The primary antibodies used and their dilutions are listed as 
follows: STARD3 at 1:3000, GSTP1 at 1:3000, GAPDH at 1:3000 (all from Cell Signaling). The 
band intensities were visualized by ImageQuant LAS 4000 (GE Healthcare) and quantified using 
Quantity One software (Bio-Rad).  
Statistical Analysis 
 Data analyses were performed using SPSS version 24 (IBM SPSS Statistics). Unequal 
variances were evaluated prior to ANOVA analysis using Levene’s test. Two-way ANOVA was 
performed to assess effects on gene expression of diet and brain region, or diet and retina region. 
Gene expression in brain, retina, or RPE-choroid regions was analyzed by one-way ANOVA, 
with Bonferroni’s multiple comparison test. In case of unequal variances, the Welch’s ANOVA 
was used to compare group means, followed by Dunnett’s T3 test for posthoc comparisons. Two-
tailed Student’s t-test was performed to assess differences in serum cholesterol and 
apolipoproteins between breastfed and all formula-fed monkeys (with the two formula groups 
combined). The correlations between pairs of variables were determined by Pearson’s linear 
correlation coefficient. All data are presented as mean ± SEM. All differences or relationships 




Lutein and Zeaxanthin Levels in Serum, Brain and Retina Dependent upon Dietary 
Sources after 6 Months of Feeding 
 As previously reported (24), after 6 months of feeding, lutein and zeaxanthin 
differentially accumulated in numerous tissues of infant monkeys in the different feeding groups 
(Table 4.2). Breastfed infant monkeys had several-fold higher lutein levels than either formula 
group in serum, both retina regions (MR and PR), and both brain regions (OC and CB). 
Compared to unsupplemented formula, supplemented formula significantly enhanced lutein 
levels in the serum, both brain regions, and PR, but not in the MR. Serum and brain zeaxanthin 
were only detectable in the breastfed monkeys. Breastfed monkeys had higher zeaxanthin 
concentrations in both retina regions compared to the formula-fed monkeys. Supplemented 
formula increased zeaxanthin levels in the PR, but not in the MR compared to unsupplemented 
formula. As expected, lutein and zeaxanthin concentrations were higher in the MR than in the PR 
in all dietary groups. In brain, lutein concentrations were higher in the OC than in CB in all 
feeding groups. 
Serum Total Cholesterol, HDL Cholesterol, and Apolipoprotein Levels 
 No differences were found between the two formula-fed groups in any lipoprotein 
measure, and therefore the two groups were combined for subsequent analyses. Serum total and 
HDL cholesterol levels were higher in the breastfed infants than in the combined formula-fed 
groups (1.2-fold and 1.7-fold higher, respectively) (Table 3). Serum lutein concentrations were 
positively and significantly correlated with HDL cholesterol (R2=0.197, P=0.034) but the 
positive correlation with total cholesterol did not reach statistical significance (R2=0.163, 
P=0.056). The levels of apoA-I, the major protein marker of HDL, were significantly higher in 
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the breastfed infants compared to the combined formula-fed infants. ApoB-100 is the principle 
apolipoprotein of LDL, IDL, and VLDL; apoB-48 is a major protein constituent of 
chylomicrons. Levels of ApoB-100, but not ApoB-48, were significantly higher in the breastfed 
infants than in the combined formula-fed infants.  
Carotenoid Levels in HDL and Non-HDL Fractions  
 To better understand the differential lutein accumulation in brain and retina tissues 
between breastfed and formula-fed infants, we investigated the amounts and distribution of 
carotenoids in the serum HDL and non-HDL fractions. Lutein concentrations in serum HDL and 
non-HDL fractions were significantly higher in breastfed infants compared to both formula-fed 
groups (Table 4.4). Supplemented formula significantly increased lutein concentrations in HDL 
and non-HDL fractions compared to unsupplemented formula. Breastfeeding also significantly 
increased β-carotene concentrations in HDL and non-HDL fractions compared to both formula 
groups. Zeaxanthin was only detectable in the serum of the breastfed group. Lycopene was 
detectable in the serum of the supplemented formula group and one breastfed infant.  
 The majority of lutein was found in the HDL fraction (range: 66-89%) in all dietary 
groups (Figure 4.1). β-carotene was equally distributed between HDL and non-HDL particles 
both in the breastfed and the supplemented formula group, while the percentage of β-carotene in 
the HDL fraction was significantly higher in the unsupplemented formula group compared to 
both the breastfed and supplemented formula groups. Zeaxanthin concentrations were 
significantly greater in the serum HDL fraction than in the non-HDL fraction of the breastfed 
group. Lycopene was also mainly transported by HDL in the supplemented formula group.  
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Gene Expression of Receptors, Binding Proteins, and Cleavage Enzymes in Macular and 
Peripheral Areas of RPE–choroid or Retina 
 The mRNA expression of carotenoid-related receptors (CD36, SCARB1, SCARB2, and 
LDLR) in the macular and peripheral RPE–choroid was determined by RT-PCR (Figure 4.2). 
Class B scavenger receptors are known to mediate HDL uptake (CD36, SR-B1, and SR-B2), and 
LDLR are known to be localized in the RPE (27-29). Expression of all receptor genes examined 
were significantly down-regulated in the macular RPE–choroid compared to the peripheral RPE–
choroid (CD36, P= 0.008; SCARB1, SCARB2, and LDLR, P<0.001). No significant effects of 
diet or diet × region were seen in the mRNA levels of these receptors.  
 We also analyzed expression of these receptors in the MR and PR (Figure 4.3A). Several 
lipid receptors, including CD36, SR-B1, and LDLR, are also known to be localized in the retina 
as internal lipid transport mechanisms (28, 29). While no significant diet × region interactions 
were found in mRNA expression of these receptors, expression of CD36, SCARB2, and LDLR, 
but not SCARB1, was higher in the MR than in the PR (CD36, SCARB2, and LDLR, P<0.001). 
There was a significant diet effect of SCARB2 expression in both retina regions (P=0.003). We 
also measured xanthophyll binding proteins and carotenoid metabolic proteins (Figure 4.3B). A 
two-way ANOVA revealed no significant effects of diet or diet × region interactions in mRNA 
levels of STARD3 and GSTP1; however, expression of both STARD3 and GSTP1 was 
upregulated in the MR compared to the PR (P<0.001 for both). With no effects of diet or diet × 
region interactions in BCO2, BCO1, and RPE65, we again found a significant region effect 
(Figure 4.3C); BCO2 expression was higher in the PR compared to the MR whereas expression 
of BCO1 and RPE65 showed the opposite pattern (P<0.001 for both). There were no significant 
correlations between lutein concentrations and mRNA levels in any of the examined genes in 
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either retinal region (data not shown). The limited amount of retina and RPE–choroid tissue 
didn’t allow to investigate protein expression in these tissues.   
Gene Expression of Receptors, Binding Proteins, and Cleavage Enzymes in Two Brain 
Regions 
 The expression of carotenoid-related genes was evaluated by RT-PCR in the OC and CB. 
We decided to analyze OC and CB due to their differences in lutein accumulation (OC > CB), as 
reported previously (24). No significant effects of diet or diet × region interactions were found 
for CD36, SCARB1, and LDLR expression. However, the expression of CD36 and SCARB1 was 
significantly higher in the OC compared to the CB (P=0.004 and P< 0.001, respectively), 
whereas there was no difference in LDLR expression (Figure 4.4A). There was a significant diet 
effect of SCARB2 expression in brain regions (P<0.001); post-hoc pairwise comparisons showed 
that the breastfed group had significantly lower SCARB2 expression compared to the 
unsupplemented formula group in the CB. In addition, SCARB2 expression was significantly 
higher in the CB compared to the OC (P=0.004). While there were no significant effects of diet 
or diet × region interactions in the expression of xanthophyll binding proteins (STARD3, 
GSTP1), expression of both genes was significantly different between the two regions (Figure 
4.4B). STARD3 mRNA expression was higher in the CB than in the OC (P<0.001), and this 
pattern was confirmed by Western blotting (P<0.001) (Figure 4.5). GSTP1 mRNA expression 
was significantly higher in the OC than in the CB (P<0.001); however, no significant differences 
were found in GSTP1 protein levels between the two regions (data not shown). Expression of 
genes related to carotenoid metabolism (BCO2, RPE65) showed no significant effects of diet or 
diet × region interactions (Figure 4.4C), but BCO2 and RPE65 expression levels were higher in 
the OC than in the CB (P<0.001 for both). There were no significant correlations between lutein 
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concentrations and mRNA or protein levels in any of the examined genes in either brain region 
(data not shown).   
DISCUSSION 
 We previously determined that breastfeeding substantially increased lutein accumulation 
in various tissues of infant rhesus macaques compared to infant formula-feeding, despite closely 
matched concentrations of lutein in breast milk and the carotenoid-supplemented infant formula 
(24). Given that serum lutein concentrations were strongly correlated with lutein concentrations 
in multiple tissues of infant monkeys, irrespective of diet, we assumed that intestinal absorption 
processes might be an important determinant of lutein uptake and tissue deposition. In a 
Commentary (25) that accompanied our previous paper, Dallas and Traber proposed that the 
higher bioavailability of lutein in breast milk might mainly result from the complex structure of 
the milk fat globule and milk lipases, which might optimize lutein absorption compared to 
commercial infant formulas (30). In addition, lipid composition differs between breast milk and 
infant formula, especially with respect to cholesterol and various fatty acids (31), which might 
contribute to differential absorption and tissue uptake of lutein (32). With the acknowledgement 
that several factors intrinsic to breast milk enhance the bioavailability of lutein, the current work 
explored whether breast milk or infant formulas differentially impacted the mRNA levels of 
carotenoid-related genes and their protein products, and whether changes in expression were in 
part responsible for the differential lutein deposition in brain and retina. In contrast to our 
hypothesis, the expression of carotenoid-related genes in brain and retina, except for SCARB2 in 
brain regions, were not associated with different types of feeding in infant monkeys over the first 
6 postnatal months. 
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Notably, it was demonstrated that serum total and HDL cholesterol, apoA-I, and apoB-
100 levels were higher in the breastfed infants than in formula-fed infants, suggesting that more 
HDL and LDL particles were present in the breastfed infants compared to the formula-fed 
infants. The increased number of lipoproteins via breastfeeding may contribute to the delivery of 
more lutein into the macular retina and brain of the breastfed infants compared to formula-fed 
infants since: 1) HDL is the primary vehicle for lutein delivery, 2) lutein is also efficiently 
delivered by LDL according to in vitro studies (12, 33), and 3) both HDL and LDL levels are 
higher in breastfed infants compared to formula-fed infants. In parallel with our findings, Renzi 
et al. (34) demonstrated the relationship between lipoproteins and macular pigments in a cross-
sectional study, showing that administration of atorvastatin, a 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) reductase inhibitor, decreased MPOD in adults with mild 
hyperlipidemia. Enhanced HDL and LDL cholesterol levels have been observed in breastfed 
human infants compared to those fed formula (35-37), due to the higher presence of cholesterol 
in breast milk than in infant formula, with particularly high levels in the early lactation period.  
 A novel finding from this work was that various carotenoid-related genes were 
differentially expressed among brain and retinal regions, independent of diet. The differential 
gene expression between the OC and CB and between the MR and PR appears to help explain 
the differential lutein deposition in these areas. The relationship between the expression of 
several genes and xanthophyll content in brain regions was previously demonstrated by Mohn et 
al. (38); that study showed that genetic origin of rhesus monkeys (Indian vs. Chinese) was 
related to the expression of genes involved in carotenoid and fatty acid metabolism and immune 
response in prefrontal cortex, cerebellum, and striatum. However, that study did not compare 
gene expression among the brain regions.  
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 Notably, STARD3 mRNA expression was upregulated in the MR compared to the PR, 
which may explain the higher lutein accumulation in the macula (range: 0.405 ~ 10.4 nmol/g) 
compared to the periphery (range: 0 ~ 1.74 nmol/g). Unlike the retina, in the two brain regions 
STARD3 expression patterns (CB > OC) were opposite to lutein accumulation patterns (OC > 
CB). Higher STARD3 expression in the CB compared to the OC may be due to STARD3’s 
involvement not only in binding to lutein but in cholesterol transport (39). In older human adults, 
cholesterol content is higher in the CB than in the OC (40), and in the OC cholesterol 
concentrations (10.7 mg/g (40)) are substantially higher than lutein concentrations (53.8 μg/g 
(6)). Previously, Tanprasertsuk et al. (41) showed a strong correlation between STARD3 protein 
expression and brain lutein concentrations in human infants. However, we did not find a 
significant correlation between the two variables in brain or retina in this intervention study.  
One limitation of this study is that we investigated mRNA expression of selected genes 
involved in carotenoid accumulation, in contrast to an unbiased approach such as RNA 
sequencing. Secondly, our experimental design utilized diets (breast milk and infant formulas) 
containing several carotenoids. This made it difficult to rule out the plausible interactions among 
carotenoids and clarify the sole mechanism of enhanced lutein accumulation in the brain or retina 
even though multiple carotenoids in human diets are natural and common. Interactions among 
carotenoids have an effect on carotenoid bioavailability; particularly, inhibitory interactions 
between lutein and β-carotene for intestinal absorption and uptake into retina has been observed 
(33, 42). We do not believe that the modest carotenoid levels fed in our study would have been 
high enough to result in carotenoid interactions or in alterations in gene expression. However, 
future studies should consider potential interactions, especially if carotenoids are provided as 
high dose supplements.  
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 In conclusion, contrary to our hypothesis, infant monkeys fed breast milk or infant 
formulas with low or high levels of carotenoids did not show differential expression of genes 
involved in carotenoid binding, transport and metabolism, in the retina or brain, with the 
exception of SCARB2. Given that breastfed infant monkeys had higher total and HDL 
cholesterol, apoA-I and apoB-100 levels in serum than formula-fed infant monkeys, combined 
with higher lutein concentrations in HDL and non-HDL fractions, suggests that lipoprotein levels 
may be one determinant of the higher lutein accumulation in the retina and other tissues during 
infancy. Differential bioavailability of carotenoids between breast milk and formula is apparently 
the primary driver for enhanced lutein tissue accumulation of breast-fed compared to formula-fed 
monkeys. However, the differential expression of carotenoid-related genes among retina and 
brain regions may explain some of the differences in lutein accumulation in those areas. 
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TABLES AND FIGURES  
Table 4.1 Primer sequences utilized in RT-PCR analysis. 
Gene Forward Reverse 
CD36 TGGTCAAGCCATCAAACAAA GCAACAAACATCACCACACC 
SCARB1 AGATCATGTGGGGCTACCAG GTTCCACTTGTCCACGAGGT 
SCARB2 GCTCTGGGGCTACAAAGATG TTCCCATTCCATTCCACAAT 
LDLR TACAGCACCCAGCTTGACAG TTTCCTCTTCACACCCTTGG 
STARD3 GCAAGAACTTGGAGCAGGAG GCAGCTCAGAGAGGATGACC 
GSTP1 CCGCACTCTTGGGCTCTATGG AGTCATCCTTGCCTGCCTCGT 
RPE65 GATGCTTACGTACGGGCAAT TTGTCGGTAACCTCCACTCC 








Table 4.2 Lutein and zeaxanthin concentrations in serum, retina (macular retina, MR; peripheral 
retina, PR), and brain (occipital cortex, OC; cerebellum, CB) of infant rhesus macaques after 6 
months of breastfeeding or formula feeding1.  
 




499 ± 78.0a 66.9 ± 4.97b 10.6 ± 3.78c 
Retina [pmol/g]† 
MR 5712 ± 1113a 1582 ± 253b 1323 ± 470b 
PR 877 ± 194a 156 ± 34.8b 34.9 ± 12.6c 
Brain [pmol/g]† 
OC 262 ± 56.0a 47.0 ± 3.91b 13.8 ± 0.95c 
CB 80.4 ± 15.4a 16.9 ± 1.26b 3.28 ± 1.65c 
Zeaxanthin 
Serum [nmol/L]  124 ± 20.1 nd2 nd 
Retina [pmol/g]† 
MR 2903 ± 533a 829 ± 133b 933 ± 282b 
PR 258 ± 58.2a 15.3 ± 5.98b 2.67 ± 2.67b 
Brain [pmol/g]† 
OC 95.3 ± 21.9 nd nd 
CB 37.8 ± 21.2 nd nd 
BF, breastfed (n=8); SF, supplemented formula-fed (n=8); UF, unsupplemented formula-fed 
(n=7). 1Values are means ± SEM. 2nd = not detected. Values in a row with different superscript 
letters are significantly different, P<0.05 by one-way ANOVA or Welch’s test followed by 




Table 4.3 Total cholesterol, HDL cholesterol, and apolipoprotein levels in serum of infant rhesus 
macaques after 6 months of breastfeeding or formula feeding1.  
 BF     SF UF 
Breastfed vs.  
Combined formula-fed 
(P-value) 
Total cholesterol [mmol/L] 7.23 ± 0.54 5.94 ± 0.21 5.78 ± 0.58 0.021* 
HDL cholesterol [mmol/L] 0.75 ± 0.15 0.45 ± 0.13 0.42 ± 0.08 0.048* 
ApoA-I [μg/mL] 188 ± 39.2a 106 ± 18.2b 80.5 ± 12.6b 0.050* 
ApoB-48 [μg/mL] 16.6 ± 0.85 22.2 ± 6.22 21.3 ± 1.41 0.273 
ApoB-100 [μg/mL] 993 ± 160a 641 ± 104ab 504 ± 73.8b 0.010* 
BF, breastfed (n=8); SF, supplemented formula-fed (n=8); UF, unsupplemented formula-fed 
(n=7).  
1Values are means ± SEM. Values in a row with different superscript letters are significantly 
different, P<0.05 by one-way ANOVA by Bonferroni posthoc test. *P<0.05, Significant different 




Table 4.4 Carotenoid levels in serum HDL and non-HDL fractions of infant rhesus monkeys 
either breastfed, fed a carotenoid-supplemented formula or fed an unsupplemented formula for 
six months. 
 
BF SF UF 
Lutein 
Serum HDL [nmol/L] 369 ± 58.6a 50.4 ± 4.14b 8.62 ± 3.15c 
Serum non-HDL 
[nmol/L] 
130 ± 20.8a 16.6 ± 1.45b 1.96 ± 0.69c 
Zeaxanthin 
Serum HDL [nmol/L] 88.2 ± 14.7 nd2 nd 
Serum non-HDL 
[nmol/L] 
35.6 ± 5.81 nd nd 
β-carotene 
Serum HDL [nmol/L] 66.7 ± 11.4a 30.2 ± 2.39b 17.9 ± 2.31b 
Serum non-HDL 
[nmol/L] 
68.4 ± 12.5a 25.3 ± 1.59b 8.93 ± 1.22c 
Lycopene 
Serum HDL [nmol/L] nd 319 ± 7.36 nd 
Serum non-HDL 
[nmol/L] 
15.0 ± 15.0 177 ± 5.04 nd 
BF, breastfed (n=8); SF, supplemented formula-fed (n=8); UF, unsupplemented formula-fed 
(n=7).  
1Values are means ± SEM. 2nd = not detected. Values in a row with different superscript letters 
are significantly different, P<0.05 by one-way ANOVA or Welch’s test followed by Bonferroni 




Figure 4.1 Percent distribution of carotenoid in the serum HDL fraction of infant rhesus 
monkeys either breastfed (BF, n=8), fed a carotenoid-supplemented formula (SF, n=8) or fed an 
unsupplemented formula (UF, n=7) for six months. Data are expressed as means ± SEM. 
Labeled means for each carotenoid without a common letter differ, P<0.05, by one-way 




Figure 4.2 Relative receptor mRNA expression in macular (solid bars) and peripheral (striped 
bars) RPE–choroid in infant rhesus monkeys either breastfed (BF, n=8), fed a carotenoid-
supplemented formula (SF, n=8) or fed an unsupplemented formula (UF, n=7) for six months. 
Relative mRNA levels were determined by real-time RT-PCR and normalized by ACTG1. The 
mean values for the macular RPE–choroid of the breastfed infant monkeys was set at 1.0. Data 
are expressed as means ± SEM. Diet and area effects were determined by two-way ANOVA. 
Labeled means for each gene without a common letter differ, P<0.05, by Welch’s test followed 






Figure 4.3 Relative mRNA expression for receptors (A), xanthophyll binding proteins (B), and 
cleavage enzymes (C) in the macular retina (MR, solid bars) and the peripheral retina (PR, 
striped bars) of infant rhesus monkeys either breastfed (BF, n=8), fed a carotenoid-supplemented 
formula (SF, n=8) or fed an unsupplemented formula (UF, n=7) for six months. Relative mRNA 
levels were determined by real-time RT-PCR and normalized by ACTG1. The mean value for the 
MR of the breastfed infant monkeys was set at 1.0. Data are expressed as means ± SEM. Diet 
and area effects were determined by two-way ANOVA. Labeled means for each gene without a 
common letter differ, P<0.05, by one-way ANOVA or Welch’s test followed by Bonferroni or 








Figure 4.3 (cont.) 
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Figure 4.4 Receptors (A), xanthophyll binding proteins (B), and cleavage enzymes (C) mRNA 
expression in the occipital cortex (OC, solid bars) and the cerebellum (CB, striped bars) of infant 
rhesus monkeys either breastfed (BF, n=8), fed a carotenoid-supplemented formula (SF, n=8) or 
fed an unsupplemented formula (UF, n=7) for six months. Relative mRNA levels were 
determined by real-time RT-PCR and normalized by ACTG1. The mean value for the OC of the 
breastfed infant monkeys was set at 1.0. Data are expressed as means ± SEM. Diet and area 
effects were determined by two-way ANOVA. Labeled means for each gene without a common 









Figure 4.5 Representative Western blot photographs (A) and relative protein levels (B) of 
STARD3 in occipital cortex (OC, solid bars) and cerebellum (CB, striped bars) of infant rhesus 
monkeys either breastfed (BF), fed a carotenoid-supplemented formula (SF) or fed an 
unsupplemented formula (UF) for six months. GAPDH was used as a loading control. The mean 
value for the OC of the breastfed infant monkeys was set at 1.0. Mouse adrenal tissue was used 
as a positive control. Data are expressed as means ± SEM (n=3 per dietary group in each brain 
region). Diet and area effects were determined by two-way ANOVA. No significant group 
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CHAPTER 5:  
13C-lutein is Differentially Distributed in Tissues of an Adult Female Rhesus Macaque 
Following a Single Oral Administration: A Pilot Study1 
 
ABSTRACT 
 Despite the growing awareness regarding lutein’s putative roles in eyes and brain, its 
pharmacokinetics and tissue distribution in primates has been poorly understood. We 
hypothesized that 13C-lutein will be differentially distributed into tissues of an adult rhesus 
macaque (Macaca mulatta) three days following a single oral dose. After a year of pre-feeding a 
diet supplemented with unlabeled lutein (1 μmol/kg/d), a 19-year-old female was dosed with 
1.92 mg of highly enriched 13C-lutein. Tissues of a non-dosed, lutein-fed monkey was used as a 
reference for natural abundance of 13C-lutein. On the third day post-dose, plasma and multiple 
tissues were collected. Lutein was quantified by HPLC-PDA and 13C-lutein tissue enrichment 
was determined by LC-Q-TOF-MS. In the tissues of a reference monkey, 12C-lutein with natural 
abundance of 13C-lutein was detectable. In the dosed monkey, highly enriched 13C-lutein was 
observed in all analyzed tissues except for the macular and peripheral retina, with the highest 
concentrations in the liver, followed by adrenal gland, and plasma. 13C-lutein accumulated 
differentially across six brain regions. In adipose depots, 13C-lutein was observed, with the 
highest concentrations in the axillary brown adipose tissues. In summary, we evaluated 13C-
lutein tissue distribution in a non-human primate following a single dose of isotopically labeled 
                                                 
1This chapter was the result of a collaboration of the following authors: Sookyoung Jeon, Qiyao 
Li, Stanislav S. Rubakhin, Jonathan V. Sweedler, Joshua W. Smith, Martha Neuringer, Matthew 
J. Kuchan, and John W. Erdman, Jr. 
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lutein. These results show that tissue distribution 3 days following a dose of lutein varied 
substantially dependent on tissue type.  
INTRODUCTION 
 Lutein, a 40-carbon oxygenated carotenoid, cannot be endogenously synthesized in 
mammals. Thus, the amount of lutein in the body is determined by dietary sources including dark 
green leafy vegetables, fruits, and yellow and orange egg yolks. Lutein and its isomer zeaxanthin 
selectively accumulate in the macular region of the primate retina to form yellow coloration 
(termed macular pigment) and to protect the retina against harmful blue light and oxidative stress 
(1). Epidemiological studies show that the consumption of lutein and zeaxanthin is strongly 
associated with a reduced risk of age-related macular degeneration, a leading cause of 
irreversible blindness in the United States (2, 3). Recently, it has been suggested that lutein may 
also play a role in brain function. Lutein is the predominant carotenoid in neural tissues of both 
infants and older adults even though it’s not the major carotenoid in the US diet (4, 5). When 
comparing dietary intake to brain function, several studies have reported associations between 
lutein and zeaxanthin supplementation and enhanced cognitive function in adults (6-8). 
 Despite growing interest in lutein, there has been limited research on its 
pharmacokinetics and tissue distribution in humans or nonhuman primates. Since it is difficult to 
completely deplete lutein in the body, especially in the retina (9), the use of isotopically labeled 
lutein is a good strategy to investigate its bioavailability and metabolism in vivo. Although a few 
studies have examined the time course of plasma responses to isotopically labeled lutein in 
human subjects, it is not possible in humans to obtain detailed information on tissue uptake (10, 
11). Previously, we established a carrot cell suspension culture system to produce enriched 13C-
lutein and demonstrated proof-of-principle of tissue uptake through subsequent dosing of an 
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adult female rhesus macaque (12). Expanding on that work, this pilot study investigated how 
13C-lutein was distributed into tissues of the adult rhesus macaque three days following a single 
oral dose. We hypothesized that 13C-lutein signals would be different across tissues.  
MATERIALS AND METHODS  
Animals and Diets  
 Animal care and in vivo dosing were performed at the Oregon National Primate Research 
Center at Oregon Health and Science University. All procedures in this study were approved by 
the Institutional Animal Care and Use Committee of Oregon Health and Science University, in 
accordance with the National Institutes of Health Guide for the Care and Use of Laboratory 
Animals. A female, 19-year-old rhesus macaque was fed a standard laboratory diet (Monkey 
Diet Jumbo, LabDiet) (Table 5.1), supplemented daily with 570μg/kg diet/day of unlabeled 
lutein (FloraGloR beadlets, 5% lutein, DSM) mixed into various treats such as marshmallow, 
peanut butter and chocolate for the previous 12 months. The animal was anesthetized with 
ketamine (10 mg/kg) and dosed with 1.92 mg of 13C-lutein solubilized in a mixture of 
monoglyceride and diglyceride oil (Abbott Nutrition) via orogastric intubation. The 
bioproduction, purification, and analysis of the 13C-lutein dose and details of the dosing 
procedure were described previously (12). In the lutein dose, the extent of labelling with 13C was 
as follows: all 40 carbons were labelled in 64.7 ± 0.9% of lutein molecules, 39 carbons in 27.0 ± 
0.4%, and 38 carbons in 8.3 ± 0.9%. Three days after oral dosing and after an overnight fast, the 
monkey was humanely euthanized by a veterinary pathologist under deep pentobarbital 
anesthesia. Blood was collected in tubes containing ethylenediaminetetraacetic acid (EDTA) and 
processed to obtain plasma, and tissues were collected, snap-frozen in liquid nitrogen, and stored 
at -80° C until analysis. Tissues collected included samples of liver, heart, kidney, adrenal gland 
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and quadriceps; adipose tissue from four sites (mesenteric, subcutaneous from abdomen and 
thigh, and brown axillary adipose tissues); samples of 6 brain regions (occipital, parietal and 
temporal cortex, medulla, pons, and subcortical white matter); a 4 mm punch of the macular 
retina, centered on the fovea; and peripheral retina. Tissues of a non-dosed monkey were used as 
a reference to determine the natural abundance of 13C-lutein. Throughout the text, 13C-lutein 
stands for the highly enriched 13C-lutein. Reference tissues were obtained from a male, 180-day-
old rhesus macaque, who consumed unlabeled lutein via breast milk and supplemental foods for 
six months. Analytical measurements were conducted in accordance with and approved by 
University of Illinois at Urbana-Champaign institutional biosafety committee project. 
Purification and quantification of lutein from monkey tissues 
Carotenoids were extracted in replicates with methods depending on the tissue type as previously 
described (13). Each tissue extract was reconstituted in 40 μL of ethanol/methyl tert-butyl ether 
mixture (1:1, by vol) and injected onto an Alliance HPLC system (e2695 Separation Module) 
equipped with a 2998 photodiode array detector (PDA) (Waters). The extract was separated on a 
reverse-phase C30 column (4.6 × 150 mm, 3 μm; YMC) maintained at 18 °C. A phase gradient 
method used for carotenoid separation was based on the method of Yeum et al. (14). Total lutein 
was identified via absorption spectrum, retention time, and standard comparison, and quantified 
by an external standard curve method. The lutein fraction was collected, aliquoted, and solvents 
were evaporated under argon.  
Mass spectrometry  
The dried lutein fraction was reconstituted in LC mobile phase (acetonitrile/methanol/10mM 
ammonium acetate=539:441:20, by vol; pH=4.5) prior to analysis. All samples were analyzed on 
a system consisting of a Thermo UltiMate 3000 UHPLC, a Bruker atmospheric pressure 
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chemical ionization (APCI) II source, and a Bruker maXis 4G quadrupole time-of-flight mass 
spectrometer (Q-TOF-MS). The LC separation involved 30 min of isocratic elution at 0.3 
mL/min flow rate at 20 ˚C on a Thermo Acclaim C30 column (3 µm, 2.1 × 150 mm), connected 
after a Thermo Acclaim C30 guard cartridge (5 µm, 2.1 × 10 mm). The operation parameters for 
the APCI source included: capillary 3500 V, corona 7000 nA, nebulizer 2 bar, dry gas 4 L/min, 
dry temperature 200 ˚C, vaporizer temperature 400 ˚C. Tandem MS analysis was performed for 
structure confirmation of target analytes, and high resolution and mass accuracy MS 
measurements were conducted for determination of 12C-lutein/ 13C-lutein ratios. Mass 
spectrometer calibration was performed with syringe infusion of the APCI/APPI calibrant 
solution (Fluka) before each sample run. Due to the low amount of 13C-lutein in adipose and 
brain tissues, the lutein fractions from 2-4 tissue extract replicates were combined and used for 
13C-lutein detection.  
Statistical Analysis 
 All data were presented as mean from 1–4 replicates. Repeatability of measurements was 
shown as relative standard deviation (RSD, %) = standard deviation/mean x 100%.  
RESULTS 
Accumulation of total lutein in rhesus macaque tissues 
Total lutein (unlabeled + 13C-labeled) in monkey tissues was extracted and separated by HPLC-
PDA. Figure 5.1 depicts representative HPLC chromatograms of liver extracts of the monkey 
dosed with 13C-lutein and the reference monkey obtained at 445 nm as well as the 
ultraviolet/visible absorbance spectrum of lutein. The retention time and absorbance spectrum of 
lutein were identical between liver extracts of the dosed and the reference animals. Total lutein 
was detectable in all tissues examined and was differentially distributed depending on tissue 
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type. Total lutein was most concentrated in the macular retina (5897 pmol/g), followed by 
adrenal gland and liver (3403 and 2677 pmol/g, respectively; Table 5.2).  
13C-lutein detection in rhesus macaque tissues 
The total lutein concentrations and ratios of 13C-lutein and 12C-lutein in each tissue allow the 
determination of 13C-lutein concentrations. We compared our previous method (12), which 
utilized a triple quadrupole mass spectrometer operating in multiple reaction monitoring mode 
with a Q-TOF-MS instrument. The Q-TOF-MS was superior and enabled lutein measurement 
with high accuracy and monoisotopic signal detection (mass error < 5 ppm). The ratio of 12C-
lutein and 13C-lutein was calculated from the intensities of corresponding [M–H2O+H]
+ 
monoisotopic signals observed in the same mass spectrum (12C-lutein – H2O+H: m/z = 
551.4253±0.0028 Da; 13C-lutein – H2O+H: m/z = 591.5593±0.0030 Da). Both 
12C-lutein and 
13C-lutein were observed in the dosed monkey liver, whereas 12C-lutein, but not 13C-lutein, was 
detectable in the reference monkey liver (Figure 5.2). Measurements demonstrated good 
repeatability, with RSD ≤ 3.9% for triplicate evaluations of the liver. MS/MS analysis was also 
performed for structural confirmation of 12C-lutein and 13C-lutein detection. The representative 
MS/MS spectra are shown in Figure 5.3. The matching of fragmentation patterns between 
unlabeled lutein standard (Figure 5.3A) and the dosed monkey liver extract (Figure 5.3B) 
confirmed that the m/z 591.5592 ion is a completely labeled 13C-lutein (13C40H56O) with the loss 
of one water molecule.  
 In the reference monkey, 12C-lutein, but not 13C-lutein, was detectable in all tissues 
examined. In contrast, 13C-lutein isotopomers were detected in multiple tissues of the 13C-dosed 
macaque, with the highest concentrations of 13C-lutein found in the liver (257 pmol/g), followed 
by adrenal gland (114 pmol/g), plasma (27.9 pmol/mL), kidney (5.57 pmol/g), and heart (5.36 
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pmol/g) (Table 5.2). As expected, lower signal intensity led to an increase in %RSD (data not 
shown).  
 13C-lutein was differentially deposited across brain regions. Among six different brain 
regions examined (temporal cortex, occipital cortex, parietal cortex, medulla, pons, and 
subcortical white matter), the occipital cortex exhibited the highest 13C-lutein concentration (2.47 
pmol/g), as well as the highest concentration of 12C-lutein. 13C-lutein also accumulated 
differentially among four different adipose depots, with the highest concentrations of 13C-lutein 
in axillary brown adipose tissue. 13C-lutein was undetectable in macular and peripheral retina 
samples, despite high concentrations of 12C-lutein. Except in samples with undetectable 13C-
lutein isotopomers, the profile of 13C-lutein isotopomers found in tissues of the dosed monkey 
were similar to that in the dose, with the highest amount of uniformly labeled lutein, followed by 
lutein with 39 13C and 38 13C atoms, respectively. Information on 13C-lutein concentrations in 
tissues, organ weights, and estimated blood volume (15, 16) were used to estimate the % 
recovery of the 13C-lutein dose in selective tissues. The total recovery of the 13C-lutein dose from 
tissues (plasma, liver, heart, kidney, adrenal gland and brain) was 1.4%, with the majority being 
in the liver.  
DISCUSSION 
Lutein preferentially accumulates in primate retina and brain, and this biological selectivity 
suggests critical or essential roles in these tissues. Long-term lutein supplementation leads to 
dose-dependent increases in serum lutein and macular pigment in human subjects (17). In 
addition, we recently showed that the lutein deposition in multiple tissues of infant rhesus 
macaques, including retina and brain regions, varied in response to 6 months of breastfeeding or 
formula-feeding (18). However, lutein pharmacokinetics are poorly understood. This pilot study 
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is the first to demonstrate a determination of tissue bioaccumulation patterns of a single dose of 
13C-lutein in an adult nonhuman primate.   
 We found that 1.4% of the highly enriched 13C-lutein dose was recovered in plasma and 
the measured tissues of the dosed rhesus monkey, while 13C-lutein was undetectable in any 
tissues of the reference monkey. Most of the consumed dose is assumed to be excreted via feces 
and urine, while additional dose accumulated in other unmeasured tissues. De Moura et al. 
reported that 45% of a 14C-lutein dose was excreted via feces and 10% via urine in an adult 
woman in the first 2 days following dosing (11). That study also reported that 14C-lutein was 
absorbed and appeared in the bloodstream within one hour after consumption, reaching 
maximum blood levels at 14 hours after ingestion.  
 It is noteworthy that 13C-lutein was differentially distributed depending on tissue type, 
being particularly enriched in the liver and adrenal glands. Interestingly, after 12 months of 
unlabeled dietary lutein exposure, the adrenal glands accumulated higher concentrations of total 
lutein than the liver, whereas after tracer dosing, the ratio of 13C-lutein/12C-lutein (13C/12C) in the 
adrenal glands (3.5%) was relatively lower than in the liver (10.6%), heart (7.0%), and kidney 
(6.6%). It has been reported that the adrenal glands accumulate high concentrations of 
carotenoids in humans (19), possibly due to highly expressed LDL receptors and scavenger 
receptor class B type 1 (SR-B1), as well as a high rate of lipoprotein uptake (20-22). Slow 
uptake, rapid metabolism, or enhanced export of lutein might explain the relatively low adrenal 
13C/12C ratio. In the retina, no 13C-lutein was detected, even though 12C-lutein is highly 
concentrated, particularly in macular retina. This might be attributable to slow uptake and 
turnover of lutein in the retina, as suggested in previous studies in humans (23, 24). Clearly, a 
limitation of this study is that only 1 dosed monkey was tested at one time point. Additional 
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studies at other time points, including younger monkeys of both genders, are needed to clarify if 
these observations indicate differential kinetics of lutein tissue uptake, metabolism, and/or 
recycling into circulation. 
 This pilot study demonstrates that a single oral dose of 13C-lutein enabled the tissue 
distribution to be determined in a rhesus macaque. Our current work was able to detect 13C-lutein 
isotopomers in tissues of the dosed monkey by using LC-APCI-MS with high sensitivity, 
allowing determination of its absolute content. We provide evidence to support our hypothesis 
that 13C-lutein was differentially distributed across various tissues, including multiple brain 
regions; however, it was undetectable in the retina. This suggests that distribution of lutein in the 
macaque is substantially dependent on tissue type. Follow-up studies are required to further 
investigate the pharmacokinetics of lutein. 
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TABLES AND FIGURES  
Table 5.1 Nutrient composition of a standard laboratory diet1  
 
Standard laboratory diet 
Protein, g/kg 156  
Fat (ether extract), g/kg 50  
Carbohydrate (nitrogen-free extract), g/kg 600  
Fiber (crude), g/kg 42  
Minerals2, g/kg 52  
Vitamins3 - 
Gross energy, kcal/g 4.08 
1Provided by Labdiet.  
2Minerals: calcium, 9.0 g/kg; phosphorus, 9.3 g/kg; potassium, 7.5 g/kg; magnesium, 1.8 g/kg; sulfur, 2.4 
g/kg; sodium, 2.5 g/kg; chloride, 3.7 g/kg; fluorine, 19 ppm; iron, 220 ppm; zinc, 110 ppm; manganese, 
97 ppm; copper, 21 ppm; cobalt, 0.53 ppm, iodine, 1.3 ppm; chromium, 0.01 ppm, selenium, 0.37 ppm. 
3Vitamins: carotene, 1.7 ppm; vitamin K, 3.2 ppm; thiamin hydrochloride, 8.3 ppm; riboflavin, 
8.6 ppm; niacin, 113 ppm; pantothenic acid, 60 ppm; choline chloride, 1200 ppm; folic acid, 7.9 
ppm, pyridoxine, 14 ppm; biotin, 0.1 ppm; B12, 73 ppm; vitamin A, 20 IU/g, vitamin D3, 6.7 
IU/g, vitamin E, 110 IU/kg, ascorbic acid, 0.5g/kg.  
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Lutein Monoisotopic Peak Intensities Ratios 
13C-lutein 






 13C / 12C40  
  Plasma 2762 7.07% 3.23% 0.96% 11.3% 27.92 
 
Liver 2677 6.56% 3.12% 0.92% 10.6% 257 
 
Heart 148 4.24% 2.06% 0.61% 6.91% 9.43 
 
Kidney 160 4.18% 1.84% 0.53% 6.54% 9.79 
 
Adrenal gland 3403 2.13% 1.04% 0.29% 3.46% 114 
 
Quadriceps 70.4 1.09% 0.36% nd3 1.45% 0.74 
Adipose BAT 250 0.58% 0.15% 0.04% 0.76% 1.94 
 
MAT 191 0.17% nd nd 0.17% 0.32 
 
ASAT 222 0.26% 0.06% nd 0.32% 0.74 
 
TSAT 110 0.10% nd nd 0.10% 0.11 
Brain Temporal cortex 88.2 1.77% 0.64% nd 2.41% 2.08 
 
Occipital cortex 115 1.34% 0.71% 0.14% 2.20% 2.47 
 
Parietal cortex 71.3 1.29% 0.56% nd 1.85% 1.58 
 
Medulla 28.9 1.00% nd nd 1.00% 0.29 
 
Pons 33.6 0.88% nd nd 0.88% 0.29 
  SWM 48.3 0.64% nd nd 0.64% 0.33 
Eye Macular retina 5897 nd nd nd nd nd 
  Peripheral retina 2771  nd nd nd nd nd 
1Data represents the mean from 1–4 replicates of tissue samples. 
2pmol/mL 
3nd = 13C-lutein not detected. 
BAT, brown adipose tissue; MAT, mesenteric adipose tissue; ASAT, abdominal subcutaneous 
adipose tissue; TSAT, thigh subcutaneous adipose tissue; SWM, subcortical white matter. 
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Figure 5.1 HPLC chromatogram (A) and absorbance spectrum (B) of lutein peaks from liver 






Figure 5.2 Mass spectra of the dosed monkey liver extract (A) and the reference monkey liver 
extract (B). The mass spectra were acquired during lutein elution from the column. Only the 545 





Figure 5.3 Tandem mass spectra of the fragmentation of unlabeled standard of 12C-lutein 
(12C40H56O–H2O; m/z 551.4247) (A), and the 
13C-lutein–H2O ion (m/z 591.5592) from the dosed 
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CHAPTER 6:  
α-Tocopherol Depletion in Tissues Using a Mouse Model 
 
ABSTRACT  
 α-Tocopherol (αT) is the most biologically active form of the eight vitamin E compounds 
(four tocopherols and four tocotrienols) and is the predominant form in animal tissues. Humans 
consume two sources of αT―naturally occurring (RRR-) αT and synthetic (all-racemic; all-rac) 
αT. While it is known that RRR-αT has higher biopotency than all-rac αTc, less well understood 
is the relative pharmacokinetics of RRR-αT and all-rac αT. To prepare for a RRR-αT versus all-
rac αT pharmacokinetics trial, this pilot study was carried out to determine the αT depletion in 
various organs over time using wild-type (C57BL/6J) mice. Three-week-old weanling mice were 
fed a tocopherol-stripped diet for either one, two, or three weeks during their rapid growth phase 
(beginning at weaning). At each time point, tissue αT concentrations were analyzed by HPLC-
PDA. αT concentrations in most tissues, except the brain, decreased over time. Specifically, 
three weeks of αT deprivation resulted in the following relative tissue αT concentrations 
compared to baseline: Serum (52%), liver (12%), heart (46%), spleen (36%), lungs (43%), 
kidney (33%), and adrenal gland (28%). In contrast, brain αT concentrations were consistent 
across the time points measured. In conclusion, one, two, and three weeks of tocopherol-stripped 
diet decreased αT concentrations in most tissues of rapidly growing wild-type mice. These 





 Vitamin E, a major lipophilic antioxidant, plays an essential role in various tissues, 
particularly in tissues of the central nervous system. Severe vitamin E deficiency, due to the 
genetic defects in vitamin E metabolism, leads to neurological dysfunction in humans and animal 
models (1-3), thus demonstrating the neurologic role of vitamin E. Among the eight different 
analogues of vitamin E, α-tocopherol (αT) is the most biologically active. There are two forms of 
αT―natural (RRR-) αT found in plants and synthetic (all-racemic, or all-rac) αT, which is 
composed of 8 stereoisomers from the 3 chiral carbons. The bioavailability of natural αT differs 
from that of synthetic αT due to differential retention of αT stereoisomers in the body. Hepatic 
-tocopherol transfer protein (α-TTP) has a higher binding affinity for the natural stereoisomer 
(RRR-) than the synthetic stereoisomers and is consequently protected against catabolism (4).    
 The kinetics of RRR-αT and all-rac αT using isotopically labeled tracers has been poorly 
characterized. Kaneko et al. compared the  accumulation of a single oral dose of 14C-labeled 
RRR-αT and SRR-αT over time (5). However, this study was limited in that SRR-αT is just one of 
the 8 stereoisomers of all-rac αT. Determining the time-course distribution of all-rac αT in 
tissues would be more relevant for human nutrition since all-rac αT is the commonly consumed 
synthetic form. Therefore, our long term goal is to compare the time-course accumulation of 
RRR-αT and all-rac αT by using 13C-labeled tracers. Doing so will enhance our understanding of 
the bioavailability and metabolism of these two forms of αT.  
To prepare for a RRR-αT versus all-rac αT trial, we conducted a preliminary study to 
evaluate the impact of vitamin E depletion in weanling mice for 1, 2, and 3 weeks. Results from 
this preliminary study are presented and discussed here.  
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MATERIALS AND METHODS  
Animals and Diets  
 All animal procedures were approved by the University of Illinois Institutional Animal 
Care and Use Committee. Female and male C57BL/6J mice were bred to obtain wild-type 
offspring and fed a standard AIN-93G diet (Research Diets). Male offspring were weaned at 3 
weeks of age onto a tocopherol-stripped diet, modified from AIN-93G diet (Research Diets; 
Table 6.1). All animals had free access to water and were maintained under standardized 
conditions (12 h light/dark cycle, 22 ºC, 60% humidity). All mice were housed in shoebox cages 
with 2-4 animals per cage. Five weanlings were sacrificed for baseline tissue α-tocopherol 
concentrations. Other animals were sacrificed after being fed tocopherol-stripped diet for 1, 2, or 
3 weeks. At the time of sacrifice, mice were anesthetized with isoflurane. Blood was collected 
via cardiac puncture, and serum was separated following centrifugation at 1500g for 15 min, 
frozen, and stored for analyses. The liver, lung, heart, spleen, heart, adrenal glands, epididymal 
adipose tissues, and kidneys were collected, weighted, and snap frozen in liquid nitrogen, then 
stored at -80°C for further analysis.  
Serum and Tissue αT Analyses   
 αT was extracted with methods depending on the tissue type as previously described (6). 
All extracts were stored under argon at −20 °C for less than 48 h before high pressure liquid 
chromatography (HPLC) analysis. A phase gradient method used for carotenoid separation was 
based on the method of Yeum et al. (7). Each tissue extract was reconstituted in mobile phase B 
and injected onto an Alliance HPLC system (e2695 Separation Module) equipped with a 2998 
photodiode array detector (PDA) (Waters). The extract was separated on a reverse-phase C30 
column (4.6 × 150 mm, 3 μm; YMC) maintained at 18 °C. αT was identified via absorption 
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spectrum, retention time, and standard comparison, and quantified by an external or internal 
standard curve method.  
Statistical Analysis 
 Data analyses were performed using SPSS version 24 (IBM SPSS Statistics). Unequal 
variances were evaluated prior to ANOVA analysis using Levene’s test of homogeneity of 
variance. Carotenoid concentrations in multiple tissues were analyzed by using one-way 
ANOVA, with Bonferroni’s multiple comparison test. In case of unequal variances, the Welch’s 
ANOVA was used to compare group means, followed by Dunnett’s T3 test for posthoc 
comparisons. All data were presented as mean ± SEM.  
RESULTS 
Body Weight and Organ Weights of the Wild-type Mice Fed a Tocopherol-Stripped Diet  
 After weaning at 3 weeks of age, mice gained weight over the feeding period (Table 6.2). 
From week 0 to week 1 on a tocopherol-stripped diet, mice grew rapidly with 1.9-fold increase in 
body weight. From week 1 to week 2, mice showed 1.3-fold weight gain; there were no 
significant differences in body weight between week 2 and week 3. The mice had normal body 
weight trajectories during the feeding period (8). 
 All organ weights significantly increased at week 1, 2, and 3 compared to the baseline, 
except for the brain (Table 6.2). There were no significant differences in brain weight among the 
time points. 
α-Tocopherol Concentrations in Tissues of the Wild-type Mice Fed a Tocopherol-Stripped 
Diet  
 αT concentrations differed between tissues, with the highest concentrations in the adrenal 
glands at all time points (Table 6.3). Liver showed the most rapid and significant αT decline 
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among the examined tissues. After 1, 2, and 3-weeks of tocopherol-stripped diet, liver αT 
concentrations were 15, 13, and 12% of the initial αT values, respectively. As compared to 
baseline, three weeks of tocopherol-stripped diet produced decreased tissue αT concentrations as 
follows: serum (52%), liver (12%), heart (46%), spleen (36%), lungs (43%), kidney (33%), and 
adrenal gland (28%) compared to baseline. There were no significant differences in αT 
concentrations of any examined organ except for serum between week 2 and week 3. Brain αT 
concentrations were consistent over the feeding period.  
DISCUSSION 
 In this study, we found that tocopherol-stripped diet decreased αT concentrations in wild-
type animals’ serum, liver, heart, spleen, lungs, kidneys, and adrenal glands—but not brain—
when consumed for 1, 2, or 3 weeks. Thus, feeding a tocopherol-stripped diet during the rapid 
growing period from 3 to 5 weeks of age decreased body αT status.  
 It was previously reported that vitamin E-deficient diets can decrease tissue vitamin E in 
a rat model. Bieri et al. compared the tissue depletion of αT between young and mature rats. 
They showed that the tissues of growing rats are more easily depleted than tissues of mature rats 
(9), suggesting that vitamin E becomes diluted within tissues as their masses increase. Therefore, 
for our study using young mice, we hypothesized that feeding a tocopherol-stripped diet for a 
relatively short period of time would be sufficient to decrease body αT stores. In contrast to most 
tissues, brain mass was consistent over the entire feeding period and brain αT was not decreased 
by the tocopherol-stripped diet, even after 3 weeks. In agreement with our results, Bourre et al. 
(10) showed that rat brain tissues including forebrain, cerebellum, and sciatic nerve endoneurium 




  In conclusion, we found that a tocopherol-stripped diet can decrease tissue αT 
concentrations in most tissues except for the brain of young, growing mice. The marginally 
deficient vitamin E mouse model established from this preliminary study will be used for 




Table 6.1 The composition of the AIN-93G standard diet and tocopherol-stripped diet based on 




Cornstarch 39.7  39.7 
Casein 20  20 
Maltodextrin 13.2  13.2 
Sucrose 10  10 
Fiber 5  5 
Mineral Mix1 3.5 3.5 
Vitamin Mix 12 13 
L-Cystine 0.3 0.3 
Choline bitrate 0.3 0.3 
Soybean oil 7 2.6 
1Provided by Research Diets.  
2Vitamin Mixture. 
3Vitamin Mixture without vitamin E.  
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Table 6.2 Body weight and organ weights of the wild-type mice fed tocopherol-stripped diet for 
1, 2, and 3 weeks. 
 
Week 0 Week 1 Week 2 Week 3 
Body weight [g] 7.2 ± 0.5c 13.6 ± 0.6b 17.0 ± 0.6a 19.0 ± 1.4a 
Organ weight [g]     
Liver 0.30 ± 0.05b 0.80 ± 0.07a 0.98 ± 0.06a 1.03 ± 0.10a 
Lungs 0.09 ± 0.004 0.13 ± 0.006 0.14 ± 0.011 0.15 ± 0.014 
Heart 0.06 ± 0.002 0.08 ± 0.005 0.09 ± 0.010 0.12 ± 0.007 
Whole brain 0.39 ± 0.004 0.40 ± 0.008 0.40 ± 0.008 0.41 ± 0.007 
Kidneys 0.10 ± 0.004 0.17 ± 0.010 0.21 ± 0.008 0.26 ± 0.022 
Spleen 0.04 ± 0.005 0.07 ± 0.018 0.09 ± 0.01 0.07 ± 0.007 
Epididymal adipose tissue 0.03 ± 0.001 0.09 ± 0.008 0.17 ± 0.019 0.27 ± 0.036 
Values are presented as mean ± SEM (n=5/time point).  
Labeled means for each tissue without a common letter differ, P < 0.05, by one-way ANOVA or 
Welch’s test followed by Bonferroni or Dunnett’s T3 pairwise posthoc tests.  
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Table 6.3 α-Tocopherol (αT) concentrations in multiples tissues of the wild-type mice fed a 
tocopherol-stripped diet for 0, 1, 2, and 3 weeks.  
 
Week 0 Week 1 Week 2 Week 3 
αT concentrations      
Serum, nmol/g 14.8 ± 0.8b 9.6 ± 1.1a 10.1 ± 0.5a 7.8 ± 0.9a 
Liver, nmol/g 101.7 ± 60.6 15.2 ± 1.5 12.9 ± 1.0 11.9 ± 1.5 
Heart, nmol/g 45.3 ± 1.7a 24.5 ± 7.4ab 21.3 ± 2.3b 20.6 ± 1.4b 
Brain, nmol/g 12.5 ± 1.0 12.8 ± 1.0 13.8 ± 0.5 13.6  
Spleen, nmol/g 52.9 ± 4.6a 26.5 ± 2.9b 21.5 ± 1.3b 18.9 ± 0.6b 
Lungs, nmol/g 36.0 ± 1.6a 38.1 ± 18.3ab 16.1 ± 1.2b 15.6 ± 0.6b 
Kidneys, nmol/g 42.6 ± 2.7a 23.0 ± 3.9b 15.5 ± 0.4b 14.2 ± 1.3b 
Adrenal glands, nmol/g 194.4 ± 10.8a 85.2 ± 8.9b 73.7 ± 13.5b 54.5 ± 6.3b 
Values are presented as mean ± SEM (n=3-5/time point).  
Labeled means for each tissue without a common letter differ, P < 0.05, by one-way ANOVA or 
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CHAPTER 7:  
Summary and Future Directions 
 
 Lutein and vitamin E (αT) carry out important functions in the body. However, neither 
nutrient is endogenously synthesized by humans, so their deposition and subsequent functions in 
tissues depend on intake from dietary sources. Lutein selectively accumulates in the macular 
region of the primate retina where it appears to protect against harmful blue light and oxidative 
stress. Unlike most carotenoids, lutein also preferentially accumulates in the neural tissues of 
infants and older adults. Several researches have shown that lutein intake was associated with 
enhanced cognitive function in adults and children, and it may therefore play an essential role in 
brain health. Likewise, αT—and more specifically RRR-αT—may help maintain neurological 
health throughout the lifespan. Previous studies have shown that RRR-αT is the predominant αT 
form in the human infant brain and that RRR-αT prevents degeneration of the cerebellar Purkinje 
neurons in aging adult mice. Although the mechanisms of selective accumulation for lutein and 
αT may differ, their selective accumulation implies that they serve functional roles in these 
tissues, particularly in the brain. This dissertation reports upon the bioavailability and 
bioaccumulation of lutein and αT in experimental models, as this information is an important 
prerequisite for understanding potential functions. 
 In Chapter 2, we investigated the bioaccumulation of lutein in infant rhesus macaques fed 
infant formulas containing either high or low levels of carotenoids (lutein, zeaxanthin, β-carotene 
and lycopene) for 4 months. As hypothesized, the carotenoid-supplemented infant formula 
enhanced lutein accumulation in multiple tissues. Because this initial study used only 4 animals 
(2 per group) and did not have a breastfed control group, we performed a second study (Chapter 
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3) to account for these limitations. Specifically, in Chapter 3, we investigated the 
bioaccumulation of lutein in infant rhesus macaques following breastfeeding or formula-feeding. 
From birth to 6 months, a total of 23 male and female rhesus macaques (Macaca mulatta) were 
either breastfed, fed a formula supplemented with lutein, zeaxanthin, β-carotene and lycopene, or 
fed a formula with low levels of these carotenoids. Breastfed infant rhesus macaques had higher 
lutein concentrations in serum, brain regions, retina, and other tissues than in monkeys who 
consumed either formula, even though the breast milk and carotenoid-supplemented formula had 
similar lutein concentrations. Compared to the unsupplemented formula-fed infants, animals fed 
the supplemented formula had enhanced lutein deposition in serum and multiple tissues, 
including all examined brain areas, but not in the macular retina. 
 In Chapter 4, we assessed whether the higher lutein bioaccumulation in the retina and 
brain of breastfed, compared to formula-fed, infant monkeys was associated with higher levels of 
serum total and HDL cholesterol, apolipoproteins, or mRNA/protein expression of carotenoid-
related genes (CD36, SCARB1, SCARB2, LDLR, STARD3, GSTP1, BCO1, BCO2, or RPE65). 
Dietary regimen did not affect the expression of carotenoid-related genes, except for SCARB2. 
However, carotenoid-related genes were differentially expressed across brain (occipital cortex 
and cerebellum) and retina (macula and periphery) regions. Additionally, breastfed infants had 
higher serum total cholesterol, HDL cholesterol, and apolipoproteins than formula-fed infants. 
This suggests that lipoprotein levels are one important for delivering lutein to tissues, especially 
the macular retina, during infancy. However, we speculate that the enhanced lutein 
bioavailability in breast milk largely results from the macronutrient matrix of milk, rather than 
lipoprotein levels or carotenoid-related gene expression. 
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 In Chapter 5, we assessed the distribution of lutein into tissues of an adult rhesus 
macaque after a single oral dose of isotopically-labeled lutein. One, 19-year-old female macaque 
was supplemented daily for a year with unlabeled lutein. She was subsequently provided a single 
dose of highly enriched 13C-lutein and then sacrificed on the third day after dosing. 13C-lutein 
was differentially distributed across tissues, including the analyzed brain regions, but it was 
undetectable in the retina. This pilot study demonstrated that distribution of lutein in the 
macaque was substantially dependent on tissue type. Studies with younger animals and at 
additional time points are needed to determine if these observations indicate differences in the 
kinetics of tissue uptake, metabolism, or recycling into circulation.  
 In Chapter 6, we evaluated the effects of a tocopherol-stripped diet on αT tissue 
accumulation using wild-type mice. Weanling mice were fed a tocopherol stripped diet for 0, 1, 
2, or 3 weeks (n=5/time point). In general, mice fed a tocopherol-stripped diet for a longer period 
of time had lower αT concentrations in multiple tissues. However, in contrast to most tissues, the 
brain maintained baseline αT levels, even after 3 weeks of dietary αT restriction. 
 In summary, we have provided insight into the lutein biodistribution profiles of breastfed 
as compared to formula-red infant monkeys, as well as a possible mechanism to explain the 
differential accumulation of lutein in the primate retina, brain, and other tissues. Our studies 
highlight the superiority of breast milk over infant formula in terms of lutein bioavailability, 
which is likely due to many factors, such as their differing milk lipid-matrices. These factors 
should be considered when developing new infant formulas in order to improve carotenoid 
bioavailability. Additionally, we determined tissue bioaccumulation patterns of a single dose of 
13C-lutein using an adult nonhuman primate model. More studies are needed to determine dietary 
recommendations for lutein throughout the lifespan. Considering lutein’s putative roles in eye 
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and brain development, a particular emphasis should be put on establishing recommendations for 
infants. Finally, the molecular mechanisms underlying the biological functions of lutein in the 
developing or aged brain should be investigated. These studies should elucidate the critical roles 
of lutein in brain health across the lifespan.   
Additionally, we showed that feeding young, growing wild-type mice a tocopherol-
stripped diet for 3 weeks decreased αT levels in most tissues. Using this marginally αT-deficient 
model, we will next investigate the time-course accumulation of 13C-natural versus synthetic αT 
in various organs. That study will allow us to compare the bioavailability of the two αT forms in 
adolescent mice and provide some insight into the pharmacokinetics and relative biopotency of 
natural αT and synthetic αT. Future studies should be performed to analyze the relative 
accumulation of each αT stereoisomer in multiple tissues, especially in the brain tissue. These 
studies will provide some foundational information about the biological function of extrahepatic 
α-TTP and will allow us to better understand the role of RRR-αT in brain health. Altogether, 
future work should provide insight into whether human dietary αT recommendations should 
emphasize the consumption of one αT form over the other. 
 
